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Summary 
Staphylococcus aureus is one of the most important pathogens in humans and 
animals. S. aureus is currently the most common cause of infections in 
hospitalized patients. The bacterium infects diverse tissues and causes a wide 
spectrum of diseases, suggesting that it possesses a repertoire of distinct 
molecular mechanisms promoting bacterial survival in disparate in vivo 
environments. 
A variety of in vitro systems have been developed that simulate certain aspects 
of the infectious process, enabling the development of screens to study bacterial 
gene expression and the behaviour of mutant strains in physiological conditions 
that reflect the situation in vivo. In vitro assays have been enormously useful and 
continue to provide much information on the mechanisms of bacterial 
pathogenesis, but it is obvious that they cannot accurately reproduce all aspects 
of the host-pathogen interaction. A pathogen may encounter several radically 
different environments in the host, and it may therefore have very different 
requirements at various points during infection, particularly in the context of a 
developing immune response. Consequently, a gene that seems important in in 
vitro studies may not be important in vivo, and genes that appear unimportant in 
an in vitro assay may play a critical role during a natural infection. 
For these reasons, in vivo experimental models are highly desirable. Recently, 
methods have been developed that enable the identification of genes that are 
expressed or required for in vivo growth. Most of these methods fall into two 
broad classes. In vivo expression technology (IVET) is a promoter-trap strategy 
designed to identify genes whose expression in induced in a specific 
environment, typically that encountered in a host. Signature-tagged mutagenesis 
(STM) uses comparative hybridisation to isolate mutants unable to survive 
specified environmental conditions and has been used to identify genes critical 
for survival in the host. Both methods have been used to identify virulence genes 
in S. aureus. The main aim of this project was to find any probable new genes of 
S. aureus that are essential for biofilm formation and infection mouse model by 
STM. 
A library of tagged insertion mutants of S. aureus and a series of selected tags 
in plasmids of S. aureus strain RN6390 were used. Most of the experiments with 
X111 
both the library and selected tags had problems with cross-hybridisation. All the 
selected tags were therefore sequenced and 33 tags with less than 50% identity 
were chosen for future experiments. A library of 825 mutants was made with the 
33 selected tags. The mutants were arrayed in 25 pools of 33 mutants. Different 
tests were done to determine that the new library was reliable for a cross- 
hybridisation free screening. The library was then used in an infection model in 
mouse and biofilm formation. A total of 12 mutants with significantly reduced 
signals were sequenced. 7 out of 12 attenuated mutants showed homology to 
different genes in S. aureus and other bacteria. Tetrahydrodipicolinate 
succinylase homolog, opp-2F, acetoin utilization AcuC protein, phosphate ABC 
transporter, dapD, branched-chain-amino-acid transporter, pepF, and flaR genes 
were identified. This work was the first STM screening in a biofilm system, and 
the dapD gene was identified in a biofilm for the first time. 2 out of 12 genes had 
also been identified in previous STM screens. 5 out of 12 attenuated mutants 
showed homology to some hypothetical proteins. A hypothetical protein of the 
same locus was identified in two mutants. 
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Part I 
Introduction 
Chapter 1 
Introduction 
Chapter 1: Introduction 
1.1 Microbiology of staphylococci 
1.1.1 Morphology 
The name staphylococcus is derived from the Greek term staphyle, meaning "a 
bunch of grapes". This name refers to the fact that the cells of these gram-positive 
cocci grow in a pattern resembling a cluster of grapes. However, staphylococci are 
spherical cells about 1 µm in diameter arranged in irregular clusters. Single cocci, 
pairs, tetrads, and chains are also seen in liquid cultures and clinical material. Young 
cocci stain strongly gram-positive. On ageing, many cells become gram-negative. 
Staphylococci are non-motile and do not form spores (20,119). 
Staphylococcal species occur worldwide as commensals on the skin of animals and 
man. They are also found on mucous membranes of the upper respiratory tract and 
lower urogenital tract and as transients in the digestive tract. They are comparatively 
stable in the environment. Staphylococcal strains display a selective affinity for 
particular animal species. Transfer of S. aureus strains between animal species and 
between animals and man is limited (138). 
1.1.2 Taxonomy 
The genus currently comprises 32 species and 15 serotypes, many of which are 
found on humans. The species most commonly associated with human disease are S. 
aureus (the most virulent and best-known member of the genus), S. epidermidis, S. 
saprophyticus, S. capitis, and S. haemolyticus (119). S. aureus is the only species 
found in humans that produces the enzyme coagulase, which differentiates it from the 
other species that are referred to as coagulase-negative staphylococci (20,119). 
1.1.3 Biochemical and metabolic characteristics 
Staphylococci are nonmotile, aerobic or facultatively anaerobic, and catalase- 
positive and grow in a medium containing 10% sodium chloride and at a temperature 
ranging from 18°C to 40°C. Relatively simple biochemical tests can be used to 
differentiate S. aureus and the other staphylococci. S. aureus has positive reactions for 
coagulase, heat-stable nuclease, alkaline phosphatase and mannitol fermentation. 
Differentiation of the coagulase-negative staphylococci is more complex, however, 
and is not routinely done in many clinical laboratories unless the isolates are 
demonstrated to be clinically significant (119). 
1.1.4 Laboratory identification 
Staphylococci grow readily on most bacteriological media under aerobic or 
microaerophilic conditions. They grow most rapidly at 37°C but form pigment best at 
room temperature (20-25°C). The most important staphylococcal species is S. aureus, 
which is named for its yellow-pigmented colonies (aureus = golden) as the result of 
the carotenoid pigments that form during their growth. Colonies on solid media are 
round, smooth, raised, and glistening. S. aureus usually forms grey to deep golden 
yellow colonies. S. epidermidis colonies usually are grey to white on primary 
isolation; many colonies develop pigment only upon prolonged incubation. No 
pigment is produced anaerobically or in broth. Various degrees of haemolysis are 
produced by S. aureus and occasionally by other species. Peptostreptococcus species, 
which are anaerobic cocci, often resemble staphylococci in morphology (20,119, 
160). 
1.2 Epidemiology 
Staphylococci are ubiquitous: All persons have coagulase-negative staphylococci on 
their skin, and transient colonization of moist skin folds with S. aureus is common. 
Colonisation of umbilical stump, skin, and perineal area of neonates with S. aureus is 
common. S. aureus and coagulase-negative staphylococci are also found in the 
oropharynx, gastrointestinal tract, and urogenital tract. Short-term or persistent S. 
aureus carriage in older children and adults is more common in the anterior 
nasopharynx than in the oropharynx. Approximately 15% of normal healthy adults are 
persistent nasopharyngeal carriers of S. aureus, with a lighter incidence reported for 
hospitalised patients, medical personnel, persons with eczematous skin diseases, and 
those who regularly use needles either illicitly or for medical reasons. Although S. 
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aureus rarely causes problems in otherwise healthy people, it is commonly associated 
with infections of prosthetic devices and surgical wounds, bacteraemia, endocarditis 
and pneumonia in hospitalised patients. Many of these infections start locally (e. g., 
skin or catheter infections) then spread to the bloodstream, thus putting patients at risk 
of developing endocarditis and other metastatic complications (91,99,119). 
Because staphylococci are found on the skin and in the nasopharynx, shedding of 
the bacteria is common and is responsible for many hospital-acquired infections. 
Some characteristics of the staphylococci account for their pathogenicity, which takes 
many forms. They grow comparatively well under conditions of high osmotic 
pressure and low moisture, which partially explains why they can grow and survive in 
nasal secretions (many people carry the bacteria in their noses) and on the skin. This 
also explains how S. aureus can grow in some foods with high osmotic pressure (such 
as ham and other cured meats) or in low-moisture foods that tend to inhibit the growth 
of other organisms. The yellow pigment probably confers some protection from the 
antimicrobial effects of sunlight. Staphylococci are susceptible to high temperatures, 
as well as to disinfectants and antiseptic solutions. The organisms can survive on dry 
surfaces for long periods. The organisms can be transferred to a susceptible person 
either through direct contact or through contact with fomites (e. g., contaminated 
clothing, bed linens)(1 19,160). 
Staphylococci are among the most common causes of hospital-acquired infections, 
including bacteraemia, surgical site infections, pneumonia, and urinary tract infections 
(50,51,121). In hospitals, the areas at highest risks for severe staphylococcal 
infections are the newborn nursery, intensive care units, operating rooms, and cancer 
chemotherapy wards. Massive introduction of "epidemic" pathogenic S. aureus into 
these areas may lead to serious clinical disease. Personnel with active S. aureus 
lesions and carriers may have to be excluded from these areas (20), or at least, 
medical personnel must use proper hand-washing techniques to prevent the transfer of 
staphylococci from themselves to patients or among patients (119). 
S. aureus causes disease through the production of toxin or through the direct 
invasion and destruction of tissue. The clinical manifestations of some staphylococcal 
diseases such as impetigo, staphylococcal scalded skin syndrome (SSSS), 
staphylococcal food poisoning and toxic shock syndrome (TSS) are almost 
exclusively the result of toxin activity, whereas other diseases result from the 
proliferation of the organisms, leading to abscess formation and tissue destruction. 
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1.3.1.2 Beta toxin 
P toxin, also called sphingomyelinase C, is a 35 KDa heat-labile protein produced 
by most strains of S. aureus. This enzyme has a specificity for sphingomyelin and 
lysophosphatidylcholine and is toxic to a variety of cells, including erythrocytes, 
leukocytes, macrophages, and fibroblasts. It catalyses the hydrolysis of membrane 
phospholipids in susceptible cells, with lysis proportional to the concentration of 
sphingomyelin exposed on the cell surface. This is believed to be responsible for the 
differences in species susceptibility to the toxin. Beta-toxin displays species- 
dependent activity. Sheep, cow, and goat erythrocytes are most sensitive. Human 
erythrocytes are intermediate in sensitivity, whereas murine and canine erythrocytes 
are resistant. The degree of erythrocytes sensitivity depends on membrane 
sphingomyelin content. The role of ß toxin in human disease remains to be proved; 
however, together with a toxin, it is believed to be responsible for the tissue 
destruction and abscess formation characteristic of staphylococcal diseases (51,119). 
1.3.1.3 Gamma-toxin 
Gamma-toxin is able to lyse human, sheep, and rabbit erythrocytes as well as human 
lymphoblastic cells. Gamma-toxin, leukocidin, and other bicomponent toxins are a 
family of proteins encoded by hlg and luk PV loci. All of the toxins in this family 
contain two synergistically acting proteins: one S component (LukS-PV, H1gA, or 
H1gC) and one F component (LukF-PV or HIgB) designated on the basis of their 
mobility (slow or fast) in ion-exchange chromatography. The prototype bicomponent 
toxins are the closely related Panton-Valentine leukocidin ((PVL) and gamma-toxin. 
The PVL S and F components are LukS-PV and LukF-PV. Gamma-toxin likewise 
contains S and F components designated HIgA and H1gB, respectively (51). 
Synergistic function involves sequential binding of the F and S components. The 
action of gamma-toxin on erythrocytes involves initial binding of H1gB (F) followed 
by HIgA (S) and subsequent generation of a pore (38,44). 
Studies have shown that the genes for gamma-toxin are transcribed from a single 
locus, located on a 4.5-kb Scal-digested chromosomal fragment. Extracts from a clone 
containing this fragment were haemolytic and leukotoxic. The open reading frames, in 
order, are named hlgA, hlgC, and hlgB, and they correspond to previous identified 
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gamma-toxin genes. hlgC and hlgB are transcribed on a single mRNA, while hlgA is 
separately expressed (45). 
1.3.1.4 Delta toxin 
6 toxin is a3 KDa polypeptide produced by almost all S. aureus strains and the 
majority of other staphylococci. The toxin has a wide spectrum of cytolytic activity, 
affecting erythrocytes, other eukaryotic cells, many other mammalian cells, 
organelles, and spheroplasts and protoplasts, as well as intracellular membrane 
structures. This relatively non-specific membrane toxicity is consistent with the belief 
that the toxin acts as a surfactant disrupting cellular membranes by means of a 
detergent-like action. It has also been reported to be dermonecrotic and lethal in 
experimental animals when used in high concentration. The activity of delta-toxin is 
inhibited by phospholipids (36,119). 
6 toxin is a 26-residue long peptide encoded by the hlg gene with peak production at 
the end of the exponential growth phase and can be purified by different procedures 
(17). The toxin has different affinity for different cells such as neutrophils, 
monocytes, lymphocytes, and erythrocytes (3). The toxin acts by formation of pores 
in the membrane, leading to the lysis of erythrocytes and other mammalian cells. At 
least two variants of 6 toxin exist; toxins expressed by human and canine strains of S. 
aureus are only 62% identical and are immunologically distinct (51). 
1.3.1.5 Leukocidin 
S. aureus can express a toxin that specifically acts on polymorphonuclear 
leukocytes. Phagocytosis is an important defence against staphylococcal infection so 
leukocidin should be a virulence factor. Its name arises from the fact that it can kill 
leukocytes (of which neutrophils are one type). Panton-Valentine Leukocidin (PVL) 
consists of two protein components, S and F. The S component is like the B part of an 
A-B toxin, in that it binds to GM1 gangliosides. However, both have enzymatic 
activity, involved in phospholipids and phosphatidylinositol metabolism, respectively. 
Phosphatidylinositol, an important signalling molecule in eukaryotic cells, controls a 
number of cellular processes. Thus, the action of this two-component toxin appears to 
-alter phospholipid metabolism and cause disruption of normal cellular activities (36, 
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141). The two components of the PVL bind sequentially to human neutrophils, 
although most reports indicate that the S component binds first and subsequently 
forms pores (31). 
1.3.1.6 Exfoliative toxins A and B 
Two serologically distinct exfoliative toxins have been described, designated 
exfoliative toxin A (ETA) and exfoliative toxin B (ETB). These toxins cause SSSS, 
usually seen in new-borns and characterised by intraepidermal separation of layers of 
the skin at the desmosomes. The illness begins abruptly with a generalised erythema, 
often near the mouth and spreading over the entire body in the course of a few days. 
When the skin is lightly rubbed, the epidermal layer wrinkles irreversibly, giving rise 
to the characteristic positive Nikolsky sign. Later, large flaccid sterile bullae appear 
that lead to separation through the stratum granulosum layer. The entire sequence 
from disease onset to recovery is 7 to 10 days. There is no permanent scarring on 
areas of the skin, and the causative toxins are not themselves lethal to the host (36). 
1.3.1.7 Toxic shock syndrome toxin-1 
TSS is characterised by fever, hypotension, and rash followed by desquamation and 
the involvement of multiple organ systems. It is toxin mediated. Toxic shock 
syndrome toxin-1 (TSST-1), formerly called pyrogenic exotoxin C and enterotoxin F, 
is an exotoxin secreted during the growth of some strains of S. aureus and can 
reproduce most of the clinical manifestations of TSS in an experimental rabbit model 
(rash and desquamation are not seen). TSST-1 has not been found in staphylococcal 
isolates from all patients with TSS, but most of these isolates not producing TSST-1 
are reported to produce enterotoxin B. The role of this second toxin in TSS has not 
been adequately defined. Coagulase-negative staphylococci can also produce TSS 
(118). 
1.3.1.8 Enterotoxins 
Staphylococcal enterotoxins (SEs) belong to a large family of staphylococcal and 
streptococcal pyrogenic exotoxins (PT), sharing common phylogenetic relationships, 
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structure, function, and sequence homology. The PT family is composed of SEs, 
TTST-1, and streptococcal pyrogenic exotoxins (SPE). Nine serologically distinct 
staphylococcal enterotoxins (SEA through SEE and SEG through SEJ) have been 
identified (14). The enterotoxins are resistant to hydrolysis by gastric and jejunal 
enzymes and are stable to heating at 100°C for 30 minutes. Thus once a food product 
has been contaminated with enterotoxin-producing staphylococci and the toxins have 
been produced, reheating the food will not be protective. Staphylococcal food 
poisoning is the leading cause of food-borne microbial intoxication worldwide and is 
usually linked to improper storage of food (76). The SEs are stable in the 
gastrointestinal tract and indirectly stimulate the emetic reflex centre. Although the 
vagus nerve is involved, molecular events involved are unclear. There is mounting 
evidence that mast cell activation occurs and that inflammatory mediators and 
neuropeptide substance P are released upon SE activity in the gastrointestinal tract 
and elsewhere (2,145). S. aureus and S. epidermidis produce these toxins, with 30% 
to 50% of all S. aureus strains producing an enterotoxin (118). 
1.3.2 Staphylococcal enzymes 
1.3.2.1 Coagulase 
Coagulase production is the principal criterion used in the clinical microbiology 
laboratory for the identification of S. aureus. Although a few strains of S. aureus do 
not produce detectable amounts of coagulase, all strains seem to possess a coagulase 
gene (coa) (163). S. aureus strains possess two forms of coagulase: bound (also called 
clumping factor) and free. Coagulase bound to the staphylococcal cell wall can 
directly convert fibrinogen to insoluble fibrin and cause the staphylococci to clump. 
The cell-free coagulase accomplishes the same result by reacting with a globulin 
plasma factor (coagulase-reacting factor) to form staphylothrombin, a thrombinlike 
factor. This factor catalyses the conversion of fibrinogen to insoluble fibrin. 
Coagulase is used as a marker for the virulence of S. aureus. The role of coagulase in 
the pathogenesis of disease is speculative, but coagulase may cause the formation of a 
fibrin layer around a focal staphylococcal abscess, thus localising the infection and 
protecting the organisms from phagocytosis. However, coagulase-negative mutants 
were less virulent than the parental strain in a mouse model of blood-borne 
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staphylococcal pneumonia (144). This suggests that coagulase may be more important 
in some types of infections than in others (51,118). 
1.3.2.2 Catalase 
All staphylococci produce catalase, which catalyses the conversion of toxic 
hydrogen peroxide to water and oxygen. Hydrogen peroxide can accumulate during 
bacterial metabolism or after phagocytosis (118). Different toxic forms of oxygen are 
produced as inadvertent by-products during the reduction of 02 to H2O in respiration. 
These reactive oxygen intermediates have many deleterious effects on living 
organisms, ranging from DNA strand damage to peroxidatiori of membrane lipids. 
Bacteria have evolved enzymes that destroy toxic oxygen products. The most 
common enzyme in this category is catalase, which attacks hydrogen peroxide 
(H202)(80,102). 
1.3.2.3 Hyaluronidase 
Hyaluronidase hydrolyses hyaluronic acids, the acidic mucopolysaccharides that 
hold together certain cells of the body, particularly cells in the connective tissue. This 
digesting action is thought to be involved in the tissue blackening of infected wounds 
and to help the microorganism spread from its initial site of infection. For therapeutic 
use, hyaluronidase may be mixed with a drug to promote the spread of the drug 
through a body tissue. More than 90% of S. aureus strains produce this enzyme (118, 
160). 
1.3.2.4 Fibrinolysin 
Fibrinolysin, also called staphylokinase, is produced by virtually all S. aureus 
strains and can dissolve fibrin clots. Staphylokinase is distinct from the fibrinolytic 
enzymes produced by streptococci (36). 
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1.3.2.5 Lipases 
All strains of S. aureus and more than 30% of the strains of coagulase-negative 
staphylococci produce several different lipases. As their names implies, these 
enzymes hydrolyse lipids, an essential function to ensure the survival of staphylococci 
in the sebaceous areas of the body. It is believed that these enzymes must be present 
for staphylococci to invade cutaneous and subcutaneous tissues and for superficial 
skin infections such as furuncles (boils), and carbuncles to develop. Lipases break fats 
down into their fatty acid and glycerol components. Each component is then 
metabolised separately (118,160). 
1.3.2.6 Nuclease 
A thermostable nuclease (TNase) is produced by nearly all strains of S. aureus and 
has been used as a diagnostic criterion for this species. TNase hydrolyses single- and 
double-stranded DNA and RNA at the 5' position of phosphodiester bonds by a 
calcium-dependent mechanism. The role of this enzyme in the pathogenesis of 
infection is unknown (51,118). 
1.3.2.7 Penicillinase 
More than 90% of staphylococcal isolates were susceptible to penicillin in 1941, the 
year the antibiotic was first used clinically. However, resistance to penicillin quickly 
developed, primarily because the organisms could produce penicillinase (beta- 
lactamase). The enzyme cleaves the ß-lactam ring of the penicillin molecule. The 
widespread distribution of this enzyme was ensured by its presence on transmissible 
plasmids (118,160). 
1.3.3 Other factors 
1.3.3.1 Capsule 
A loose-fitting, polysaccharide layer (slime layer) is only occasionally found on 
staphylococci cultured in vitro, but it is believed to be more commonly present in 
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vivo. More than 90% of clinical isolates of S. aureus produce capsular 
polysaccharides. Eleven capsular serotypes have been identified in S. aureus, with 
serotypes 5 and 8 associated with the majority of infections (136). These capsules can 
also be divided into two distinct groups on the basis of colony morphology. Mucoid- 
type capsules include the serotype 1 and 2 capsules; strains producing these capsules 
are heavily encapsulated and are mucoid on solid medium. Microcapsules include the 
remaining serotype 3 to 11 capsules; strains with these capsules have a thin capsular 
layer and form non-mucoid colonies on solid medium. Studies showed that the 
mucoid-type capsules were important antiphagocytic virulence factors that masked 
C3b deposited on the bacterial cell wall, preventing its recognition by receptors on 
phagocytic cells. The capsule protects the bacteria from polymorphonuclear 
leukocytes, as well as by inhibiting the proliferation of mononuclear cells after 
mitogen exposure. It also facilitates the adherence of bacteria to catheters and other 
synthetic material (e. g., grafts, shunts, prosthetic valves and joints). This property is 
particularly important for the survival of relatively avirulent coagulase-negative 
staphylococci (51,119). It has been shown that S. aureus strains that are defective in 
microcapsule production are more efficient at inducing experimental infective 
endocarditis (IE) than their parental strains, suggesting that the microcapsule may 
obscure important surface-expressed cell wall proteins involved in IE pathogenesis 
(36). 
1.3.3.2 Protein A 
The surface of most S. aureus strains (but not the coagulase-negative staphylococci) 
is uniformly coated with protein A. This protein is covalently linked to the 
peptidoglycan layer and has a unique affinity for binding to the Fc receptor of 
immunoglobulin (Ig)Gi, IgG2, and IgG4, thus effectively preventing the antibody- 
mediated immune clearance of the organism. The importance of protein A in 
staphylococcal infections is somewhat unclear. It is possible that, by binding IgG, 
protein A could interfere with the phagocytosis of opsonized bacteria via receptors on 
the host cell. Extracellular protein A can also binds antibodies, thereby forming 
immune complexes with the subsequent consumption of the complement. Recent 
studies has showed that protein A can mediate bacterial adherence to von Willebrand 
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Such diseases include cutaneous infections, endocarditis, pneumonia, empyema, 
osteomyelitis, and septic arthritis. In the presence of a foreign body like a splinter, 
catheter, shunt, prosthetic valve or joint, significantly fewer staphylococci are 
necessary to establish disease. Likewise, patients with congenital diseases associated 
with an impaired chemotactic or phagocytic response, such as Job-Buckley syndrome, 
Wiskott-Aldrich syndrome, and chronic granulomatous disease, are more susceptible 
to staphylococcal diseases (51,119). 
1.3 Virulence factors of staphylococci 
1.3.1 Staphylococcal toxins 
1.3.1.1 Alpha toxin 
a toxin (a haemolysin) which is encoded on the bacterial chromosome, is a 33 KDa 
polypeptide that is produced by most strains of S. aureus. The toxin disrupts the 
smooth muscle in blood vessels and is toxic to many types of cells, including 
erythrocytes, leukocytes, hepatocytes, platelets, and cultivated cells. It becomes 
integrated in the hydrophobic regions of host cell membrane, leading to formation of 
1- and 2-nm ring-shaped pores (51). The rapid efflux of K+ and influx of Na+, Cat+, 
and other small molecules leads to osmotic swelling and cell lysis. The sensitivity to 
this varies for animal species (rabbit erythrocytes are 1000-fold more sensitive than 
are human cells) and cell type (e. g., fibroblasts can repair membrane damage more 
effectively than can erythrocytes). Cells such as rabbit erythrocytes are suspected to 
have high-affinity binding sites, while other cells such as human erythrocytes have 
only low-affinity sites (75). a toxin is believed to be an important mediator of tissue 
damage in staphylococcal disease (119). a toxin is also an important cause of damage 
to the air-blood barrier in S. aureus-induced pneumonia (109). Most S. aureus isolates 
posses hla, the structural gene for alpha-toxin, but are variable in its expression or in 
the amount of toxin expressed. Work with mutants in animal models indicated that 
strains expressing alpha-toxin are more virulent than isogenic derivatives (51). 
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factor, an extracellular matrix protein important in normal hemostasis, suggests that 
protein A may play additional roles in the infectious process (51). 
The presence of protein A has been exploited in some serological tests, in which 
protein A-coated S. aureus is used as a non-specific carrier of antibodies directed 
against other antigens. Additionally, detection of protein A can be used as a specific 
identification test for S. aureus (119). 
1.4 Regulation of virulence determinants 
S. aureus surface proteins, such as adhesins and protein A, a major surface antigen, 
are produced early in growth in vitro and their production is down-regulated at a later 
time. Most secreted proteins, such as toxins, haemolysins, and tissue-degrading 
enzymes, are produced at the end of exponential phase. The production of all of these 
factors (the virulence response), is controlled primarily by a global regulatory locus 
agr (42), which has been shown in several experimental infection models to be 
required for virulence (47,48,134). 
The agr locus (66,70-72) consists of two divergent transcription units using 
promoters P2 and P3 (figure 1.1)(126). The P2 operon contains four genes, agrA, B, 
C, and D. Genes agrA and C represent a classic two-component signal transduction 
pathway, of which agrC encodes the signal receptor and agrA the response regulator 
(82,98,101). The other two genes, agrB and D, combine to produce the autoinducer, 
a small peptide that is the ligand that binds to and activates AgrC (30). AgrD encodes 
the autoinducer propeptide (30) and AgrB encodes a protein that is required for 
processing and possibly for secretion of the autoinducer (104). AgrC is a 
transmembrane protein that is phosphorylated at a conserved histidine residue in 
response to the autoinducer in vitro (112). The last extracellular loop of AgrC is 
sufficient for binding of the autoinducer and the subsequent activation by 
phosphorylation. The primary role of the agrAC signaling pathway is to up-regulate 
both of the major agr promoters, P2 and P3, which it does in conjunction with a 
second transcription factor, SarA (114,118). It may also up-regulate the coagulase 
gene (125), but does not directly regulate any of the other known agr-dependent 
genes. The P3 operon specifies a 512 nucleotide transcript, RNA III, that is the 
effector molecule of the agr regulon (70,71), and happens to encode the 26 amino 
acid S-hemolysin which is not involved in regulation. RNA III up-regulates 
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Figure 1.1 The agr system. (a) A schematic diagram, showing the two divergent agr promoters 
(P2 and P3) and their transcripts. The P2 operon contains four genes, agrA, B, C, and D. Two of 
these, agrC and agrA, represent a two-component signal transduction pathway and the other two, 
agrB and D, combine to generate a peptide that is the activation ligand for the signal receptor. 
The function of the signalling pathway is to activate the two agr promoters so that there are two- 
levels of positive feedback (open arrow). The P3 transcript, RNA III, regulates transcription of 
30 or more unlinked target genes, including hla the a-hemolysin gene, by an unknown 
mechanism. (b) A blow-up of AgrD, showing the amino acid sequence of the autoinducing peptide 
(AIP) (in bold) that serves as activating ligand for the pathway by binding to AgrC. (c) A blow-up 
of AgrC, showing five transmembrane helices, predicted by sequence analysis and confirmed by 
phoA fusions. Deletion analysis suggests that the last eatracellular loop is the site of AIP binding, 
which causes the predicted phosphorylation of a conserved histidine (11) in the carboxy-terminal 
cytoplasmic domain (126). 
transcription of the secretory protein genes and down-regulates transcription of the 
surface protein genes by an as yet unknown mechanism that probably involves 
proteins encoded by genes outside of the agr locus. RNA III also and independently 
regulates translation of at least one product a-hemolysin by complementary pairing 
with the hla mRNA leader region, which, in the absence of RNA III, folds into an 
untranslatable configuration (70,133). 
1.5 Staphylococcal diseases in human 
It is important to keep in mind that the staphylococci that cause disease in humans 
and animals are not inherently pathogenic organisms (unlike the influenza virus, for 
example, which must cause disease to propagate). For every illness caused by 
staphylococci, many more individuals are benignly colonised with no sign of disease. 
It is important to realise that no single virulence factor produced by a 
Staphylococcus has been shown to date to be either necessary or sufficient for the 
establishment of an infection, although the infective or lethal dose does vary. No 
strain has yet been identified that produces all the known toxins, or even members 
from all toxin families. 
The narrowest definition of a virulence factor would be a substance that, when 
purified to homogeneity and introduced into a test animal, produces a pathogenic 
effect. Using that definition, most of the virulence factors especially those involved in 
attachment and probably most of the degradative enzymes (e. g., lipases, proteases, 
and hyaluronidase) would not be considered true virulence factors. In the broadest 
sense, any substance that is exported out of the cytoplasm either to the cell surface or 
into the extracellular environment of the Staphylococcus can be thought of as a 
potential virulence factor. Clearly, those substances that are capable of interacting 
with the host may affect that host in some deleterious way. This second definition is 
probably too broad and in many cases it is possible that the production of at least 
some of these factors may actually assist the host in combating an infection (36). 
1.5.1 Bacteraemia and infective endocarditis 
S. aureus and coagulase-negative staphylococci (CoNS) are ideal infective 
endocarditis (IE) pathogens in that they possess a number of virulence factors, which 
13 
enable them to establish 1E. Acute endocarditis caused by S. aureus is a serious 
disease, with a mortality rate approaching 50%. Although patients with S. aurcus 
endocarditis may initially have non-specific influenza-like symptoms, their condition 
can deteriorate rapidly and include disruption of cardiac output and peripheral 
evidence of septic embolization. Unless appropriate medical and surgical intervention 
is instituted immediately, the patient's prognosis is poor. In addition, S. aureus 
continues to be an important cause of both community-acquired (CA) and hospital- 
acquired (HA) bacteraemia. Commonly associated predisposing medical conditions 
include diabetes mellitus and renal insufficiency. Most patients with S. aureus 
bacteraemia have an obvious primary focus of infection, usually an intravascular 
catheter. Overall mortality in patients with S. aureus bacteraemia remains high, 
particularly in the absence of a removable primary focus, older age patients, rapidly 
fatal comorbid conditions, underlying respiratory or cardiac disease, associated 
infective endocarditis (IE), and septic shock. Methicillin-resistant S. aureus (MRSA) 
bacteraemia is a growing problem globally (36,119). 
1.5.2 Wound infections 
Staphylococcal infections of the skin can be minor or life threatening, depending on 
the integrity of the skin surface and the invasiveness of the bacterial strain. 
Staphylococci are the most common species recovered from patients who develop a 
wound infection after surgery, with S. aureus and the CoNS rank first and third 
among aerobic bacteria associated with wound infections, respectively. In general, 
staphylococci that cause wound infections come from the flora of the patient or the 
personnel performing the procedure. For S. aureus, studies have shown that the 
patient's own flora serves as the source of the infecting bacteria in about one-half of 
cases of surgical infections (36,51). 
1.5.3 Infections of intravascular catheters and vascular devices 
Although intravascular catheters and vascular grafts have revolutionised the practice 
of medicine for the betterment of patients, unfortunately they are associated with a 
significant incidence of infection. Staphylococci, both S. aureus and CoNS, play a 
pre-eminent role in these infections. Because of their unique environmental niche on 
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the skin and mucus membranes of humans and their ability to adhere to biomaterials 
and cause infection, they will undoubtedly continue to cause significant morbidity and 
mortality as the use of prosthetic medical devices increases. From 20% to 65% of all 
infections of catheters and shunts are caused by CoNS. The CoNS are particularly 
well adapted for causing these infections because they can produce a polysaccharide 
slime that bonds them to catheters and shunts and protects them from antibiotics and 
inflammatory cells. A persistent bacteraemia is generally observed in patients with 
infections of shunts and catheters because the organisms have continual access to the 
blood stream (36,119). 
1.5.4 Skin and soft tissue infections 
Staphylococci are inhabitants of the skin and mucous membranes of mammals and 
birds, where they exist saprophytically. However, factors ranging from tight clothing 
or scratching to immunosuppression or insertion of a prosthesis alter the host-parasite 
relationship and cause disease. Colonisation, particularly of the nares by S. aureus, 
leads to hand carriage, and from the hands, the organisms are frequently spread to 
other areas of the body. Thus, staphylococci often follow a nose to hands to wounds 
route of infection (172). The variety of enzymes and toxins produced, especially by S. 
aureus, results in a spectrum of disease, part of which may be a direct expression of 
the toxin damage, but also a result of a variety of pathogenicity factors acting in 
concert. Purulent skeletal muscle infection (pyomyositis), folliculitis and furuncles, 
recurrent furunculosis, impetigo, botryomycosis and secondary cutaneous infection in 
patients with eczema are some staphylococcal infections due to S. aureus (36). 
1.5.5 Central nervous system 
The staphylococci are important causative organisms of cerebrospinal fluid (CSF) 
shunt infections, acute purulent meningitis, brain abscess associated with trauma, 
spinal and cranial subdural empyema and epidural abscess. CoNS are the etiologic 
organisms in most CSF shunt infections. S. aureus is the second most common 
pathogen. The staphylococci typically enter the shunt system from a contaminated 
wound or from the patient's skin surface at operation. 
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S. aureus is the causative organism in most cases of staphylococcal meningitis that 
develop as a complication of a neurosurgical procedure, from a parameningeal focus 
of infection or a congenital anomaly or during the course of staphylococcal 
bacteraemia or endocarditis. S. aureus is a common causative organism of brain 
abscesses that develops as a result of cranial trauma, either penetrating wounds of the 
brain or craniotomy. S. aureus is the causative organism in most cases of spinal 
subdural empyema and in 15 to 25 percent of cases of cranial subdural empyema. 
CoNS are isolated on rare occasion from cranial subdural empyemas. S. aureus is the 
causative organism in 50 to 60 percent of spinal epidural abscess and in most cranial 
epidural abscesses that occur as a complication of craniotomy or compound skull 
fracture (36). 
1.5.6 Diseases of the eye 
Staphylococcal diseases of the eye include both infections and expression of cell- 
mediated immunity (CMI) to staphylococcal antigens. The pathogenesis of diseases 
due to both S. aureus and CoNS has been increasingly well-characterised in recent 
years (36). A model of staphylococcal keratitis in guinea pig has been described (41), 
and a similar model in rats was used to determine the effects of antibiotics and 
corticosteroid treatments on the progression of S. aureus infection of the cornea (10). 
Radial incision of the rabbit conjunctiva followed by inoculation of S. aureus resulted 
in purulent conjunctivitis and a model for testing antimicrobial treatments in this 
disease (16). 
1.5.7 Osteomyelitis and other infections of bones and joints 
Colonization of the bones and joints by S. aureus may occur as a result of either 
hematogenous infection or it can be a secondary infection resulting from trauma or 
the extension of disease from an adjacent area (51,119). During the 1970s, most cases 
of osteomyelitis were caused by strains of S. aureus. During the 1990s, although the 
incidence of osteomyelitis caused by gram-negative pathogens has increased 
dramatically, staphylococci are still the most commonly isolated pathogens in most 
types of osteomyelitis. S. aureus is the most frequent single pathogen in adults, 
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accounting for 50 to 70 percent of cases of osteomyelitis. The estimated frequency of 
S. aureus in pyogenic osteomyelitis in all age groups may reach 80 to 90 percent (36). ' 
S. aureus is the primary cause of septic arthritis in young children and in adults who 
are receiving intra-articular injections or who have mechanically abnormal joints. 
Secondary involvement of multiple joints is indicative of hematogenous spread from a 
localised focus. Staphylococcal arthritis is characterised by a painful, erythematous 
joint, with purulent material obtained on aspiration. Infection is usually demonstrated 
in the large joints (e. g., shoulder, knee, hip, and elbow). The prognosis in children is 
excellent, but in adults, it depends on the nature of the underlying disease as well as 
the occurrence of any secondary infectious complications (119). 
1.5.8 Respiratory tract infections 
S. aureus, in distinct contrast to the CoNS, is a significant cause of respiratory tract 
disease. S. aureus respiratory disease can develop after the aspiration of oral 
secretions or from the hematogenous spread of the organism from a distant site. 
Aspiration pneumonia is seen primarily in the very young, the aged, and patients with 
cystic fibrosis, influenza, chronic obstructive pulmonary disease, and bronchoiectasis. 
Hematogenous pneumonia is common for patients with bacteraemia or endocarditis. 
While S. aureus is not among the most frequent of isolates from patients with 
sinusitis, bronchitis, or pneumonia, it is isolated from patients with these illnesses. 
Although S. aureus is an uncommon cause of severe community-acquired pneumonia, 
it is responsible for perhaps 20 to 30 percent of cases of nosocomial pneumonia (36, 
51,119). 
1.5.9 Urinary tract infections 
Although staphylococci are not commonly thought of as causes of urinary tract 
infection (UTI), S. aureus may cause UTI. The infections range from asymptomatic 
bacteriuria to infections that are severe and associated with bacteraemia. Given the 
relative frequency with which the perineal area is colonised with S. aureus, it is 
perhaps surprising that this organism is relatively uncommonly recovered as a cause 
of UTI (36). S. saprophyticus has a predilection for causing UTI in young, sexually 
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active women and is rarely responsible for infections in other patients. It is also 
infrequently found as an asymptomatic colonizer of the urinary tract (119). 
1.5.10 Toxin-mediated syndromes 
Three diseases are associated with specific toxins: (i) toxic shock syndrome (TSS), 
caused by toxic shock syndrome toxin type 1 (TSST-1), (ii) food poisoning, by 
staphylococcal enterotoxins; and (iii) staphylococcal scalded skin syndrome (SSSS) 
by exfoliative toxins. Two other diseases are probably related to staphylococcal 
toxins: staphylococcal enterocolitis, caused by staphylococcal enterotoxins or 5-toxin; 
and severe wound infections associated with a-toxin (36). 
Staphylococcal toxic shock syndrome (TSS) is an illness that is the result of the 
protean effects of one or more toxins of S. aureus (36). Staphylococcal TSS may 
manifest in either of two general forms, menstrual or nonmenstrual. Menstrual TSS 
occurs in women whose vaginal/cervical mucosa are colonised by TSST-1-producing 
S. aureus. Tampon use is a risk factor in menstrual TSS, and a correlation between 
tampon absorbency and risk of developing TSS has been established. TSS acquired in 
this way is difficult to reproduce in animals, although some success has been achieved 
with a simulation of tampon use in rabbits. Attempts have also been made to induce 
TSS or a TSS-like syndrome by other means in laboratory animals (137), but a 
definitive model for this disease has not been forthcoming. Nonmenstrual TSS may 
result from S. aureus infection elsewhere in the body. Either staphylococcal 
enterotoxins (SEs) or TSST-l may mediate the nonmenstrual form (51). TSST-1 in 
the bloodstream can trigger a massive release of cytokines that cause shock and death. 
In animals, TSST-1 makes the animal hypersusceptible to LPS, which may enter the 
bloodstream regularly in small amounts because of lysis of gram-negative bacteria in 
the intestine. However, LPS might not even be the most important molecule whose 
action is potentiated by TSST (141). 
Staphylococcal food poisoning, one of the most common foodborne illnesses, is an 
intoxication rather than an infection. Disease is caused by bacterial toxin present in 
food rather than from a direct effect of the organisms on the patient. Certain strains of 
S. aureus can also cause enterocolitis, which is manifested clinically by watery 
diarrhoea, abdominal cramps, and fever. Enterocolitis occurs primarily in patients 
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who have received broad-spectrum antibiotics, which suppress the normal colonic 
flora and permit the growth of S. aureus (119). 
Staphylococcal scalded skin syndrome (SSSS) is characterised by the abrupt onset 
of a localised perioral erythema (redness and inflammation around the mouth) and 
formation of the bullae or skin blisters and a potential for widespread peeling. The 
lesions cover the entire body within 2 days. The disease is predominant in children. 
Bullous impetigo is a localised form of SSSS. Specific strains of toxin-producing S. 
aureus are associated with the formation of superficial skin blisters. Unlike patients 
with the disseminated manifestations of SSSS, patients with bullous impetigo have 
localised blisters that are culture-positive (51,113,119). 
1.6 Veterinary aspects of staphylococci 
The first systematic study of pathogenic staphylococci was done by Rosenbach in 
1884. The association of staphylococci with veterinary medicine began with the 
isolation of the organisms from mastitis in sheep by Nocard in 1887. In 1890 
Guillebeau reported that staphylococci were responsible for mastitis in cattle. Thus 
within six years of the first systematic study of pathogenic staphylococci in 1884, the 
importance of staphylococci in veterinary medicine was established (48). S. aureus, S. 
intermedius, and the coagulase-variable S. hyicus are important pathogens of domestic 
animals. Although coagulase-negative staphylococci are usually of low virulence, 
some occasionally cause disease in animals (138). 
1.6.1 Bovine mastitis 
Mastitis is an inflammatory reaction of the mammary gland. The most important 
mastitis pathogen, worldwide, is S. aureus. Staphylococcal mastitis may be 
subclinical, or clinical. The majority of infections are subclinical. In the clinical form, 
the disease may be peracute, acute, or chronic. Peracute and gangrenous forms are 
associated with severe systemic reactions and can be life threatening. The peracute 
form, which is rare, is caused by S. aureus, often shows a gangrenous udder, and is 
frequently fatal. In gangrenous mastitis the affected quarter, which becomes cold and 
blue-black, eventually sloughs. Tissue necrosis is attributed to the alpha-toxin which 
causes contraction and necrosis of smooth muscle in blood vessel walls, impeding 
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blood flow in the affected quarter. In addition, this toxin causes release of lysosomal 
enzymes from leukocytes. Usually, staphylococcal mastitis begins with an acute 
episode, including some or all of the cardinal signs of inflammation in the udder: 
tumour, rubor, calor, and dolour and functio laesa. Systemic signs of disease are not 
always seen. If not successfully treated, the acute form becomes chronic, with few 
clots in the milk, or with no clinical signs; the disease subsequently passes into a 
subclinical, chronic form. An elevated somatic cell count and isolation of bacteria 
from the milk can only detect this form of mastitis (66,138). 
The route of infection in staphylococcal mastitis is via the teat, and the milking 
machine is considered to be the most important predisposing factor. However, 
staphylococcal mastitis does occur in hand-milked cows, in suckled cows, and during 
the dry period. The bacteria pass the teat duct into the teat and udder cisterns, and 
subsequently into the milk ducts. They may subsequently establish in an area of 
secretory tissue. S. aureus and other mastitis pathogens, at 37°C, are able to rise with 
the milk fat. The phenomenon seems to involve IgA antibodies associated with 
membranes of fat globules in previously infected animals. This phenomenon may aid 
to invade upper parts of the milk ducts and udder. 
The mechanism of penetration via the teat duct is not fully understood, but it is 
suggested that the organisms gain entrance to the teat cistern by propulsion and/or by 
bacterial growth. The staphylococci colonise the tip of the teat, especially in areas of 
teat lesions or erosions. Colonisation often precedes an intramammary infection but 
does not always result in mastitis. Staphylococci can colonize the teat duct for a 
prolonged period of time. In the intact teat, the organisms probably exist as distinct 
microcolonies in the stratum corneum, as they do in other areas of skin. When contact 
is made between the staphylococci and milk, then a medium is provided in which the 
staphylococci can grow into the gland. The nearer the organisms are to the milk in the 
teat cistern, the greater is the risk for mammary infection to occur. Once the 
organisms pass the barriers of the teat duct, adherence to epithelial cells is thought 
(but still not proven) to be the next critical step in pathogenesis. Adherence is 
believed to involve a combination of cation-bridging, hydrophobic interactions, and 
bacterial adhesin-specific epithelial surface receptors. It has been shown that the 
ability of S. aureus to bind to epithelial cells of the ductules and alveoli in the bovine 
mammary gland is an important virulence factor, and that antibodies against whole 
cells inhibit the adherence. 
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Once established on the surface, nucleases and phosphatases degrade pus into 
substances that can be utilised as nutrients for the bacteria. Although several potential 
virulence determinants have been purified, or partly purified, and tested for toxicity in 
different experimental systems, their relative importance as virulence determinants is 
not known (66). 
The mouse model of intramammary inoculation has been used extensively in 
studying this disease and represents a reproducible and cheap simulation of the 
disease in dairy cattle (26). Various attempts have been made in the past to design 
vaccines directed against the bacterial surface polysaccharides and proteins (adhesins) 
and against the toxins of S. aureus and to test their efficacy in bovine, mouse, and 
rabbit models (52,156). More recently, a live attenuated S. aureus strain was used to 
provide protection in mice when inoculated locally during late pregnancy or early 
lactation (60). 
1.6.2 Mastitis in other species 
Staphylococci are capable of causing mastitis in domestic animals other than the 
cow though these infections are far less well documented than staphylococcal mastitis 
in the cow. In broad terms the mode of infection and the host defence mechanisms are 
similar to those that operate in the cow. However, staphylococcal mastitis has been 
seen in other species such as sheep, goats, pigs, rabbits, dogs, cats and horses (48). In 
sheep and goats, the mastitis is predominantly of the gangrenous type (66). 
1.6.3 Exudative epidermitis 
Exudative epidermitis (greasy pig disease) is an acute generalised dermatitis, caused 
by S. hyicus, which involves the entire body surface of pigs 5-35 days of age. It is 
highly contagious and is characterised by hyperhidrosis, excess sebaceous secretion, 
exfoliation and exudation but no pruritis. These changes result in a loss of skin 
function, extreme dehydration and rapid exhaustion, which may terminate in death. 
Piglets under 3 weeks of age may die within 24 to 48 hours. Morbidity rates range 
from 20% to 100%, and mortality rates can reach 90% in severely affected litters. S. 
hyicus can be isolated from the vaginal mucosa and skin of healthy sows. The 
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organisms probably enter the skin of young pigs through minor abrasions such as bite 
wounds (48,138). 
Prevention of the disease is by scrubbing the sow with a suitable disinfectant prior 
to entering the furrowing crate. The furrowing crate and pen should be clean and all 
sharp edges and ridges should be removed (48). 
1.6.4 Tick pyaemia of lambs 
Tick pyaemia is a prenatal infection of lambs with S. aureus, characterised by 
septicaemia and death or by bacteraemia and the localisation of staphylococci in 
various tissues. In the bacteraemic form of the disease arthritis or meningitis may first 
appear during the first 2-4 weeks of life; there may also be suppurative lesions in the 
skin, muscles, tendon sheaths and viscera especially the heart and kidneys. Tick 
pyaemia was originally found to co-exist with louping ill, tick-borne fever, lamb 
dysentery and pulpy kidney disease (48,138). 
The association between the disease and hill-grazing regions of Britain and Ireland, 
where there are suitable habitats for the tick Rodes ricinus, is strong (138). 
The first line in control of tick pyaemia must be to ensure that hygienic conditions 
exist for lambing and carrying out surgical procedures so that staphylococcal 
contamination and infection is reduced to a minimum (48). 
1.6.5 Staphylococcosis of poultry 
As in other animals the staphylococci that cause disease in poultry are inhabitants of 
the skin of the animals and do not differ biochemically from other skin staphylococci. 
The lesion traditionally associated with staphylococci in poultry is bumblefoot. This is 
a localised bulbous lesion of the ball of the foot, which arises from the penetration of 
a foreign body followed by secondary invasion by S. aureus. Lameness is often the 
first symptom of the condition and the swelling may not be obvious until the planter 
aspect of the foot is examined. However, if S. aureus gains entrance to the circulation 
of birds, then a septicaemia is produced which if not fatal, leads to arthritis and 
synovitis (48). S. aureus can also cause arthritis and septicaemia in turkeys, and 
omphalitis in chicks (138). 
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1.6.6 Pyoderma 
Pyoderma is one of the most common skin diseases of dogs, but it is relatively rare 
in cats. Coagulase-positive Staphylococcus is the most commonly isolated organism 
from pyoderma in dogs. Prior to 1982, the organism was called S. aureus, but 
subsequently it has been identified as S. intermedius. It is suggested that changes in 
sebum production provide a milieu in which S. intermedius may multiply (66). 
1.6.7 Endometritis 
The clinical features of endometritis vary from species to species. Frequently no 
more is observed in the cow than a slight vaginal discharge and repeated return to 
service. On the other hand the bitch usually presents as an endometritis which has 
advanced to pyometritis. The uterus is palpably enlarged, there is a vaginal discharge, 
anorexia and depression. There are often signs of concomitant renal involvement such 
as polyuria, nocturia and polydipsia (48). 
1.7 Treatment and vaccines 
Staphylococci quickly developed drug resistance after penicillin was introduced and 
today less than 10% of the strains are susceptible to this antibiotic. This resistance is 
mediated by penicillinase which hydrolyses the ß-lactam ring of penicillin. The 
genetic information encoding the production of this enzyme is carried on 
transmissible plasmids, which facilitated the rapid dissemination of resistance among 
staphylococci. 
Because of the problems with penicillin-resistant staphylococci, semisynthetic 
penicillins resistant to ß-lactamase hydrolysis (e. g., methicillin, nafcillin, oxacillin, 
dicloxacillin) were developed. Unfortunately, the staphylococci developed resistance 
to these antibiotics, as well. S. aureus which is resistant to an antibiotic called 
methicillin is referred to as methicillin-resistant Staphylococcus aureus or MRSA. 
Currently, 30% to 50% of the strains of S. aureus and more than 50% of the 
coagulase-negative staphylococci are resistant to these semisynthetic penicillins. 
Resistance occurs as the result of acquisition of a gene, mecA, that codes for a novel 
penicillin-binding protein, PBP2'. The penicillins and other ß-lactam antibiotics kill 
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bacteria by their ability to bind to penicillin-binding proteins, which are enzymes 
responsible for construction of the cell wall peptidoglycan. PBP2' is not bound by 
penicillins but retains its enzymatic activity. 
Staphylococci have demonstrated the remarkable ability to develop resistance to 
most antibiotics. Until recently, the one antibiotic that has remained uniformly active 
against staphylococci has been vancomycin, the current antibiotic of choice for 
treating staphylococci resistant to oxacillin. Unfortunately, isolates of S. aureus have 
been found with decreased susceptibility to vancomycin, and frank resistance to 
vancomycin has been observed in coagulase-negative staphylococci. The mechanism 
of this resistance is unknown. However, there is evidence that changes in cell wall 
synthesis have led to reversible vancomycin binding that effectively prevents 
vancomycin from disrupting peptidoglycan synthesis (119). 
Until the 1970s a variety of whole staphylococcal preparations was used in clinical 
and veterinary trials as a vaccine. These included cultured, attenuated, fixed or lysed 
organisms. None showed convincing benefit in patients, animal models or farm 
animals. Staphylococci were known to produce haemolysins and leukocidins. Toxoids 
prepared from these were largely unsuccessful as vaccines and were accompanied by 
many adverse reactions. Some toxoids of veterinary value, such as the alpha toxoid, 
protect ewes against gangrenous mastitis, did not reduce the overall infection rate. 
Polyvalent polysaccharide components of the bacterial wall have given some 
success in animal models. However, clinical trials of staphylococcal vaccines, 
including those utilising polysaccharides, were beset with problems with loss of 
potency of vaccine material and difficulties in interpretation of trial data (48,116). 
Aerosol vaccination with S. aureus endotoxins have shown good results in animal 
models and now await clinical trials. In last few years, scientists have tried DNA 
vaccination against the clumping factor A (C1fA) and passive immunisation with 
monoclonal antibodies as new strategies in staphylococcal vaccination (116). The 
results suggested that DNA immunization against adhesins represents a new and 
valuable approach to combat S. aureus infections (21). 
1.8 In vivo methods for studying bacterial virulence genes 
For more than a century, microbiologists have tried to investigate how bacteria 
cause disease by measuring phenotypes and attributes of the organism in vitro. It has 
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only recently become evident, however, that some genes essential for pathogenesis 
are turned on only during infection in the host. Thus, no number of adherence assays, 
enzyme studies, or electron microscopic examinations of cultured microorganisms 
would reveal a property that is only expressed in vivo. 
Much of our knowledge about the virulence determinants of pathogenic bacteria 
comes from experiments with bacteria grown in culture, but there is currently an 
increasing interest in what happens to bacterial pathogens in the infected host. 
Bacterial pathogenicity is a multifactorial property that is only fully manifested in 
vivo, where environmental conditions differ from those in laboratory cultures. These 
conditions are not only more complex than those in vitro but change as infection 
proceeds in response to inflammation, tissue breakdown and spread from one site to 
another. Bacterial behaviour will, therefore, be mediated in vivo by changes in the 
availability of nutrients and substrates and the effect of these changes on the 
regulation of gene expression. Bacterial pathogens in vivo will, consequently, differ 
from those grown in vitro, an effect now confirmed for many pathogenic species. The 
environment in vivo will influence bacterial pathogenicity by controlling bacterial 
growth rate and population size and by affecting the production of virulence 
determinants. 
The fact that environmental conditions in vivo differ from those in vitro, and change 
as infection proceeds, has three implications. First, some putative virulence 
determinants indicated by experiments in vitro may not be produced in vivo. Second, 
some of the virulence determinants that are formed in vivo may not be produced in 
vitro. Third, the complement of virulence determinants may change with time and 
anatomical site. Clearly, the production in vivo of any putative virulence determinant 
has to be confirmed, and bacteria grown in vivo must be examined to discover novel 
virulence determinants. Regarding the third implication, virulence determinants must 
be identified as infection progresses, together with the host factors and regulatory 
processes that induce them (151). 
In the past few years, the study of bacterial pathogenesis has been advanced by a 
number of techniques that enable investigators to monitor bacterial gene expression 
during infection. These techniques allow the investigator to select and screen for 
genes that are required for infection or that are expressed in vivo. In particular, three 
methodologies have dramatically impacted our understanding of bacterial 
25 
pathogenesis. Table 1.1 summaries new methods for studying bacterial pathogens in 
vivo (151). 
1.8.1 In vivo Expression Technology (IVET) 
Defining the nature and function of bacterial gene products expressed during 
infection is critical to understanding the molecular and genetic mechanisms of 
pathogenesis. Recent advances in gene fusion technology have resulted in the 
development of a genetic strategy termed in vivo expression technology (IVET) that 
provides a positive selection for bacterial genes that are induced during host infection 
(82,104). The protocol for IVET is shown in figure 1.2 (67). 
IVET is a strategy for identifying bacterial genes active during mammalian infection 
but relatively inactive at other times (104). A subset of such genes encodes virulence 
factors crucial to the infection process. The novel feature of IVET is its use of 
infected mammalian tissues directly to induce expression of candidate virulence 
genes, rather than relying on one's ability to duplicate the in vivo milieu in the 
laboratory. Accordingly, it is a powerful advance over earlier gene-finding techniques 
(98). 
The IVET system has several applications in the area of vaccine and antimicrobial 
drug development. The technique has been designed for the identification of virulence 
factors and thus may lead to the discovery of new antigens useful as vaccine 
components. The IVET system facilitates the isolation of mutations in genes involved 
in virulence and, therefore, should aid in the construction of live attenuated vaccines 
(150). 
The original IVET selection was performed by creating transcriptional fusions of 
random fragments of the Salmonella typhimurium chromosome with a promoterless 
purA gene and introducing this library onto the chromosome of an S. typhimurium 
ApurA strain via homologous recombination at the chromosomal fragment. Because 
purines are limiting for growth of S. typhimurium in the mouse, only those strains 
expressing purA from fused promoters would survive (104). 
It should be noted that the integration event resulting from a single crossover does 
not lead to disruption of the wild-type locus on the chromosome, thereby permitting 
analysis of genes essential for growth in vivo. Bacteria representing the pool of 
chromosomal fusions were then injected intraperitoneally in mice, and the surviving 
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pools were recovered 3 days later and screened on laboratory medium for clones with 
low promoter activity. Several strains carrying promoters meeting the criteria of in 
vivo expression and in vitro inactivity were, on subsequent analysis, found to have 
severe virulence defects as assayed by oral LD50, thereby validating the ability of 
IVET to isolate virulence genes (29,104). 
IVET was applied to S. aureus using a promoter trap that relies on genetic 
recombination of the site-specific resolvase of tnpR from gamma delta (Tn1000) as a 
reporter gene expression. A collection of 45 genes were found induced during 
infection in a murine renal abscess model. Of these, only six had been known 
previously; 11 others have homology to known non-staphylococcal genes. The known 
staphylococcal genes included agrA, a key locus regulating numerous virulence 
products; and a glycerol ester hydrolase which may enhance bacterial survival in 
abscesses. Many of the ivi genes identified were not classical virulence factors but 
rather involved in adaptation to the in vivo environment; knowledge of these 
biochemical pathways is clearly the next phase in IVET systems (98). 
To date, there are four variations of IVET, and each relies on the generation of 
transcriptional fusions of genomic sequences to a reporter gene encoding an 
enzymatic activity. The variation in the four methods lies in the particular reporter 
gene utilized. These are (i) auxotrophy complementation-based selections, (ii) 
antibiotic selections, (iii) dual reporter selections or other types of genes that provide 
an in vivo selection and an in vitro screen for promoter activity, and (iv) 
recombination-based IVET (RIVET) (5). 
There are two limitations of IVET selections as follows: (i) ivi genes that are 
transiently expressed or expressed at a low level in vivo are difficult or impossible to 
detect because they either do not produce PurA long enough or do not produce 
enough of it to allow survival and growth of the strain and (ii) not all ivi genes are 
essential for infectivity. The first of these limitations is of unknown magnitude; 
however, it is reasonable to predict that only a subset of virulence genes that are 
transcriptionally silent in vitro will be expressed at levels sufficient for survival 
throughout the course of an infection. The second limitation, applicable to all IVET 
selections and screens, is often misconstrued, particularly since the advent of 
signature-tagged mutagenesis (STM), which is a genetic screen used to identify genes 
that are essential for infectivity (5,72). In other words, IVET is a selective method 
that positively selects the bacterial genes that are required for virulence, while STM is 
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a negative selection method for bacterial mutants that are present in the initial 
inoculum, but do not survive in the animal. STM is discussed in session 1.8.3. 
1.8.2 Differential Fluorescent Induction (DFI) 
DFI is a promoter trap in which bacterial promoters drive the expression of the 
highly sensitive reporter, green fluorescent protein (GFP). The GFP of the jellyfish 
Aequorea victoria is a unique experimental tool that permits monitoring of gene 
expression and protein localisation in living cells. GFP is stable and, unlike reporter 
molecules such as ZacZ or luciferase, it does not require cofactors for its activity. 
However, with the use of a fluorescence-activated cell sorter (FACS), in vivo- 
expressed fusions are identified by their level of expression compared with growth on 
laboratory media (70,167). 
1.8.3 Signature-tagged mutagenesis (STM) 
Mutagenesis techniques have been used extensively for the identification of genes 
whose functions are required under certain conditions. One of these techniques that 
has been used in several pathogens is transposon mutagenesis. 
Transposons are the most versatile tools for the genetic analysis of bacteria. Unlike 
the situation with chemical mutagenesis, transposons produce complete disruption of 
the mutated gene, resulting in nonleaky phenotypes; moreover, multiple insertions or 
retranspositions are rare events, and most important, the resulting phenotype is 
genetically linked to a selectable marker such as resistance to an antibiotic. The 
spectrum of different types of transposons, their mechanisms of transposition, and 
their applications in genetic engineering is an interesting subject for molecular 
biologists (42). 
One approach to identifying the traits that contribute to virulence is to make random 
mutations in the genome of a pathogen using a transposon and screen the transposon- 
generated mutants for loss of virulence (141). 
Transposons are capable of inactivating genes by insertion, and the inactivated 
genes are readily identified and recovered. A typical strategy is to construct a plasmid 
carrying the transposon, using a temperature-sensitive vector, e. g., a plasmid that is 
unable to replicate at an elevated temperature. When this plasmid is introduced into 
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bacterial cells, and the cells are grown at a temperature permissive for plasmid 
replication (e. g., 30°C), all the cells will carry the plasmid. If the culture is 
subsequently shifted to a temperature (e. g., 42°C) at which the plasmid is unable to 
replicate, the only cells that retain the transposon will be those in which the element 
has transposed onto the chromosome. It is usual to use a transposon that carries an 
antibiotic resistance gene (for example TnS, carrying a gene for kanamycin 
resistance), so these transpositions can be selected by plating the culture at 42°C on 
agar containing kanamycin. 
This generates a transposon mutant library, with the transposon inserted at a variety 
of chromosomal positions, and therefore causing a range of mutations. Once the 
mutants of interest are selected, the gene(s) into which transposon has inserted can be 
identified. This can be done as described above for deletions and insertions in general 
(i. e., by looking for a change in size of specific DNA fragments), but the presence of 
an antibiotic resistance gene on the transposon facilitates a more direct approach. If 
the total DNA is cut with a restriction enzyme (taking care to select one that does not 
cut the transposon itself), the collection of fragments can be cloned to produce a gene 
library. If this gene library is then plated on kanamycin agar, only those clones 
containing Tn5 will be able to grow. These clones will contain not only Tn5 but also 
some of the sequence on either side of it; this is the gene that has been inactivated by 
Tn5 insertion, and it can be proceeded to characterise (39). 
On the point of transposon mutagenesis in staphylococci, two transposons have 
been used successfully in S. aureus and S. epidermidis: 
(1) The closely related class II elements Tn551 and Tn917. 
(2) The closely related conjugative transposons Tn916 and Tn918 (167). 
For many applications, mutations in genes of interest can be identified by screening 
a sufficient number of mutants for a negative phenotype. Such approaches 
traditionally required individual and labour-intensive analysis of mutants for loss-of- 
function phenotype. To circumvent this limitation and link mutagenesis techniques 
with an efficient screening approach a novel technique termed "signature-tagged 
mutagenesis", or STM, was developed (71,72). Although the development of STM 
was performed for the identification of new bacterial virulence genes the principles of 
the method can be adapted to the analysis of other organisms and can be extended to 
the identification of genes whose functions are required for the successful 
colonisation of certain habitats or the exploitation of specialised metabolic features. A 
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key feature of STM is the possibility of simultaneous identification of mutants by 
negative selection. In contrast to approaches where the complementation of mutations 
can be selected as a positive phenotype, one can identify a mutation resulting in a 
negative phenotype, such as attenuation of virulence or inability to grow under certain 
nutritional conditions. A novelty of STM is that such negative selection is not 
performed by individual testing of mutants from a bank of mutants, but rather by 
collective screening of pools of mutants in a parallel manner (71). 
STM is divided into two steps: firstly, the construction of a library of tagged 
mutants, and secondly, in vivo screening of the library. In the original STM, each 
insertional mutation carried a different DNA tag, which allowed mutants to be 
differentiated from each other. The tags were prepared as a pool of oligonucleotides 
containing a variable central region flanked by conserved sequences. The central 
region was designed to ensure that the same sequence occurs once in 2x 1017 
molecules (72). Each tag comprised a different central sequence of 40bp flanked by 
invariant 'arms' of 20bp, which enable the central portions to be co-amplified by the 
polymerase chain reaction (PCR). Tags were ligated into the pUT mini-Tn5 Km2 
transposon and transferred from E. coli into the recipient host. Tagged mutant strains 
are assembled in microtitre dishes, and then combined to form the 'inoculum pool' for 
infection studies. At an appropriate time after inoculation, bacteria are isolated from 
the animal and pooled to form the 'recovered pool'. The tags in the recovered pool and 
the tags in the inoculum pool are separately amplified, labelled and then used to probe 
filters arrayed with the different tags representing the mutants in the inoculum. 
Mutants with attenuated virulence are those with tags that give hybridisation signals 
when probed with tags from the inoculum pool but not when probed with tags from 
the recovered pool (72). It became quickly apparent that the highly random DNA tags 
gave cross-hybridisation noise. The original STM tag library was screened to identify 
pools of 96 tagged mutants giving a high and specific hybridisation signal (92). Figure 
1.3 shows the design of STM protocol (130). 
When compared to traditional pathogenicity assays, STM minimises the number of 
animals to be utilised. The crux of STM depends on tagged transposon mutants 
defective in virulence that cannot be maintained in vivo. Attenuated mutants are 
selected and re-tested to confirm attenuation; disrupted genes are cloned via the 
transposon marker and identified by DNA sequencing (92). STM is based on the 
concept of monitoring the frequency of a particular mutant in a population of other 
30 
IA VR 
I 
Array mutants on 
microtitre dish 
Colony blot onto 
two membranes 
'Jr 
membranes 
with VR tags 
ri UUC 
Input pool 
I 
+ `> J__j_ ýý 
\ 
ý_ý_ _. 
/ 
Identify putative 
avirulent mutants (-) 
I Recover desired 
mutants 
Release 
[As 
In vivo 
Extract DNA, 
amplify and r 
label VR tags 
Recovered pool 
IA, invariant arms; VR, variable region; Ab', antibiotic resistance gene 
IA 
Transposon 
Pool mutants /\ Infect animal 
Figure 1.3 A diagrammatic representation of the STM screening process (130). 
mutants by marking each mutant with a distinct tag. If a mutant cannot grow in a 
particular niche, then that mutant's tag will not be detected among the recovered 
bacteria (110). 
A crucial step in STM depends on a high frequency of random transposon insertions 
into the chromosome. This is not always possible, insertion into an essential gene 
gives a lethal phenotype (defined here as genes essential for growth in vitro) and 
transposons are not easily utilised in all bacterial species. For example, STM was 
modified for insertion-duplication mutagenesis in Streptococcus pneumoniae (133) 
and shuttle mutagenesis in Neisseria meningitidis (30). In the insertion-duplication 
mutagenesis, tagged plasmids with chromosomal fragments, to facilitate homologous 
recombination in the host strain, were introduced by transformation (133). STM 
shuttle mutagenesis is performed into E. coli and resulting plasmids are transformed 
into the naturally competent microorganism (30). These methods allow the use of 
transposon mutagenesis in microorganisms where it is normally impossible to use 
STM (92). 
The original STM was also modified to augment tag specificity and reduce 
hybridisation background. The tag-screening step was done immediately after the 
initial cloning into the mini-Tn5 to select 96 tags (from the 1017) that gave specific 
hybridisation signals (112). 
In hybridisation-based STM, mutants are pooled in an in vitro culture from which 
an aliquot is used for in vivo passage. Bacterial genomic DNA is extracted from 
bacteria grown in vitro and from those recovered after in vivo selection. Mutants that 
gave a hybridisation signal from the in vitro pool but not from the in vivo pool are 
detected with respect to persisting in vivo or establishing an infection. Chromosomal 
DNA is used as PCR templates for preparation of radioactive or non-radioactive 
probes hybridised to colony or DNA dot blots from the arrayed mutant library. 
Modifications include PCR that can be done directly on bacterial cell lysates (93) and 
chemiluminescence (92,112). 
Another STM modification is based on PCR, a very powerful technique for DNA 
detection and amplification, giving a PCR-based STM without hybridisation (93). The 
initial STM-PCR was built with 12 re-usable and PCR-specific tags eliminating the 
fastidious tag-screening step. In this method, mutants from the same pool were grown 
separately, aliquots were pooled and a sample was used as the in vitro pool. A second 
sample from the same pool is used for in vivo passage (the in vivo pool). The in vitro 
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and in vivo pools are used in comparative PCR where one of the tags is used as primer 
along with a universal primer in the kanamycin resistance gene (92). 
In the first application, STM was used in Salmonella typhimurium (72) successfully 
and resulted in the identification of a chromosomal region called Salmonella 
pathogenicity island 2 (SPI2). This encodes a type III secretion system critical for 
systemic infection (112,147,167). 
Following the first STM screen in S. typhimurium (72,161), the method has been 
applied for identification and analysis of virulence factors in a vast variety of gram- 
positive and gram-negative bacteria including S. aureus (33,112,146), Salmonella 
enterica serotype Dublin (18), S. choleraesuis (96), Vibrio cholerae (28,115), 
Yersinia enterocolitica (40), Y. pseudotubereulosis (85,111), Proteus mirabilis (171), 
Pseudomonas aeruginosa (93,94), Legionella pneumophila (49,132), Brucella suis 
(54), B. abortus (77), B. melitensis (95), Listeria monocytogenes (8), Escherichia coli 
(11,12,61,107), Neisseria meningitidis (30,58,154), Streptococcus pneumoniae 
(68,89,133), S. agalactiae (81), Actinobacillus pleuropneumoniae (57), Haemophilus 
influenzae (73), Klebsiella pneumoniae (106,153), Xenorhabdus nematophila (74), 
Burkholderia pseudomallei (7) and Pasteurella multocida (56), and acid fast bacilli 
like Mycobacterium tuberculosis (25,34). STM has also been used for identification 
of virulence genes in microorganisms other than bacteria like Candida glabrata (32), 
Aspergillusfumigatus (22), Cryptococcus neoformans (122), and Toxoplasma gondii 
(86). 
Virulence in S. aureus has been studied by using STM methodology (33,112,146). 
In the study by Mei et al (112), Tn917 mutants were tested in a murine model of 
bacteraemia. The majority of loci from 50 mutants that were identified as attenuated 
were predicted by sequence similarity to be involved in cell surface metabolism (e. g. 
peptidoglycan cross-linking and transport functions), nutrient biosynthesis, and 
cellular repair processes, but most of the remainder had no known function. A slightly 
larger signature-tagged mutant bank was constructed by using the same transposon 
and tested in models of bacteraemia, abscess and wound formation, and endocarditis 
(33). This enabled the identification of various genes affecting growth and virulence 
in specific disease states, as well as 18 that are important in at least three of the 
infection models. Many of these genes appear to be involved in the same kinds of 
processes as those identified in the earlier study (112); indeed, seven of the genes 
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identified by Mei et al (112) were also found by Coulter et al (33). Tables 1.2 and 1.3 
summarise some details of the genes recovered in S. aureus by STM so far (33,112). 
1.9 Biofilms 
Biofilms can be defined simply and broadly as communities of microorganisms that 
are attached to a surface. It is clear that microorganisms undergo profound changes 
during their transition from planktonic (free-swimming) organisms to cells that are 
part of a complex, surface-attached community. Biofilms can comprise a single 
microbial species or multiple microbial species and can form on a range of biotic and 
abiotic surfaces. Although mixed-species biofilms predominate in most environments, 
single-species biofilms exist in a variety of infections and on the surface of medical 
implants (1,6,44,127). These single-species biofilms are the focus of most current 
research. P. aeruginosa has emerged as the most studied single-species, biofilm- 
forming gram-negative bacterium, although, among the gram-negative bacteria, P. 
fluorescens, E. coli, and V. cholerae have also been studied in detail. The gram- 
positive biofilm-forming bacteria that have been studied include S. epidermidis, S. 
aureus, and the enterococci (127). 
A number of gram-positive infections, including those caused by S. epidermidis, S. 
aureus, and the enterococci, have proven to be particularly difficult to treat with 
current antibiotic therapies, partly owing to their high-level natural resistance to 
antimicrobial compounds. Furthermore, these organisms become resistant to the 
highest deliverable levels of antibiotics when growing in a biofilm (38,79,139,164). 
The production of an exopolysaccharide matrix, or glycocalyx, is one of the 
distinguishing characteristics of biofilms. It has been suggested that this matrix, 
among other functions, prevents the access of antibiotics to the bacterial cells 
embedded in the community. Either reaction of the compound with, or sorption to, the 
components of the biofilm can limit the transport of antimicrobial agents to the cells 
within the biofilm (103). The actual structure of the biofilm matrix will vary greatly 
depending on the microbial cells present, their physiological status, the nutrients 
available and prevailing physical conditions (155). It is estimated that more than 60% 
of nosocomial infections are derived from biofilm-related infections (6,55,78). 
Biofilm bacteria can be up to 1,000-fold more resistant to antibiotic treatment than the 
same organism grown planktonically, but the mechanisms by which the biofilm- 
33 
ü 
y ffl M"f en M 
b0 
y i. O 
M M 
L ++w 
u, 
Z 
-4 rz 06 [z 
gi 
W 
H 
d 
w ri = :e 
2 
cl w ýt 
O 
vNi 
O 
vNi 
O 
vNi u 
O i+ H 'ý 
\ \ \ 
^O ýO-1 
H 
rl ý 
Z 
1. + 
y 
"ý 
cu 
H N b 
ý 
i3 
Q 
1 äý b a 
U2 U2 
4, 
b 
Ou "ý 
V! tÄ ... i 
".. 
E 'b 8 
oý 1. 
6) 
h 
ý 
a 
O 
L. 
v 
Ö Ö 
1 
-ýr 
1 
O 
u N N N N N 
yý 
,y 
M 
M 
M 
M 
M 
M _, -. 4 
--, 
f-1 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
_ 
-+ 
f-1 
,. 
N. 
ý 
"y 
M 
M 'r 
f1 
M 
M r. y 
-r 
Cl 
M 
M ý 
_ 
. -r "ý 
ei M M M M M 
as 
0 
ý 
b 
F7 
ä 
o 
'p 
º. a>' 
"ý .., ^ 
ý 
yO 
G ý". 
'yO. r,. 
"ii 
U 
6) 
^ 
r1 
/ý 
ý 
au ý 
ý 
ý 
. 
ýN'" 
C) 
an 
d 
¢, 
ý 
'CS 
e 
^ 
`ý.. 
`di 
"ý ' 
°, 
T3 
T3 
ý 
a 
'ý 
Ö 
". 
^. 
i 
N 
... ý 
° 
"'ý 
Ö 
. 
^-i 
ýýr 
.a C) 
Ö 
a 
a) 
5 
"ºýyy 
ý 
Ci 
"C3 
N 
ý 
O 
0 
5 
ö 
914 
.ý 
cd 
O 0 
2 
R 
cal 
ý 
G 
. 
ýi 
CA 
_ 
a 
e 
C) 
Ü 
ý v C) 
.0 ID w 
^Od 
ö 
ý 
N 
1 
oo. 
,,., 
, 
j: ý 
e 
Ö 
in 
d 
bq 
o 
p 
^ 
G 
C) 
ý w M 
c 
ö 
Ö 
V'1 
V1 
N 
cd 
. "-. 
ý 
M 
9O 
" ý 
Ü 
w 
42 
, ~ 
ý 
.0 
tu 
'ýj, 
U 
N 
`J 
c> "V 
'G 
N 
Ö 
V1 
aNi 
d 
p 
~ 
Q 
id 
P. 
Ö 
0 
ý 
-ý'' ° 
?U 
'u 
e 
ý'+ 
1. -1 
. 
'-i 
v 
'd 7 
°'ý 
h 
ý 
y 
-: 5 
ý_ 
-9 
O 
H 
Ö p 
g 
"in 
, -,. - 
U 
ý ýö 
e 
0 
;b 
f= 
W 
i 
u 
ý, 
ýý 
41, 
M 
M 
M 
M 
N 
ý""ý 
ý 
M 
M 
M 
M 
M 
M 
", 
M 
m 
M 
M 
m 
M 
M 
M 
M 
M 
M 
M 
m 
M 
M 
M rN, y 
e4 
. -Ný 
N_ 
. "Nr M M 
M 
M . "Ni 
ä M M 
0 
ý""` 
Qa 
I" 
z 
v 
C 
b 
Cl a 
ý 
O 
ä' 
N 
0 
a 
oa 
Qi 
~p+ 
4, p 
to 
Ü 
O 
^ 
^' 
llýf 
9 
° 
: ý+ 
r. 
- 
N 
PO 
Ü 
4.4 
"ý 
ö 
.ý Q 
ýý, 
03 
ö 
3 
ü 
f. + 
ä 
rn 
0 
.4 
° 
Ö 
O 
N 
o 
ý 0 
ö 
ýý' 
L) 
, ý" º4 
0 
0 
VI 
ý"1. 
Mgi' 
U 
ý 
R 
4--1 
V1 
4-4 
O 
ýM1 
- 
O 
A 
{°y 
F' 
ý N 
O 
v 
w 
ý 
w 
ýI-y 
41 
n 
N 
:: 
04 ä 
N 
w 
O 
tp 
O 
p, 
- ý 
U 
.0 
ý., 
'n' 
w 
N 
ä 
cd 
Ö 
. 4' 
° 
0 
ý 
b 
p 
"y 
^ 
0 
ý. 
U 
Ö 
N 
p, 
... 
ý 
ý 
N 
p, 
ý Yl [ý '""ý M '""' 
ý $41 
f+ 
O 
N 
N 
Cý 
U G p 
ö 
ö 
ý 
N 
_ö 
N 
N 
U 
Ü 
ý a 
ä 
ý 
Ü 
04 
Ü Ü h: 
U 
U 
}, ý 
tý: 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
'-+ 
M 
.ý ^ 
.ý O 
t7 
o 
ä. 
Pa 
^ 
ý 
ý"ýý 
00 
Cl) 
ý 
G: 
0 
0 
"ý 
N 
d 
ä 
.ý 
p 
) a 
f, 
a) 
ý 
Fi 
`-^ý 
c+-+d 
Ü 
Ö 
"° 
a 
° 
"'ý 
0 U 
O 
Ö 
ö 
"-" 
p 
ý 
ý 
4. 
Zn 
° p, 
0 
tl 
N 
d 
"ý 
Ö 
ö 
. 4, 
ý 
b 
o 
`ý 
'O 
ý 
wo 
N 
° 
Q 
ö 
.ý (D 
cd 
r'ai 
.r 
ý" 
w 
M 
'ty 
a 
ö 
Ä. 
"Ü 
4. + 
M 
ýý 
V 
ö 
2 
0 
. tyý 
ý"' 
Q 
.N 
.. 
h 
ý 
ý 
ti 
:" 
2 
t/1 
. -. 
^ý 
. taý 
" 
ýN 
o p 
ä 
r-. ` 
ý 
U 
.. N 
C7' 
ö 
i 
x+ 
Ü 
N 
0 
ý 
FUr 
z N 00 00 
O 
O 
v 
"ýy 
ö 
H 
°y 
1 
0 
bA 
ä 
.ý 
ý 
ý 
z 
grown bacteria attain this resistance are still a matter of speculation. Mechanisms of 
resistance that are considered likely include (i) phenotypic changes in bacteria 
resulting in resistance occurring within the biofilm environment, (ii) inactivation of 
the antibiotics by extracellular polymers or modifying enzymes, and (iii) nutrient 
limitation resulting in slowed growth rate (59). 
1.9.1 Staphylococcal biofilms 
Biofilm formation in staphylococci is multifactorial, and the ability to form a 
biofilm makes the strains much better able to survive in the normally hostile 
environment of tissue and blood. Numerous studies have implicated a polysaccharide 
intercellular adhesin (PIA) in biofilm formation in S. epidermidis. PIA is a 
polysaccharide composed of ß-1,6-linked N-acetylglucosamine with partly 
deacetylated residues, in which the cells are embedded and protected against the 
host's immune defence and antibiotic treatment (35,63). The ica genes code for the 
synthesis of this adhesin (35). Mutations in ica operon lead to a pleiotropic 
phenotype; the cells are biofilm- (35) and haemagglutination-negative, less virulent 
and less adhesive on hydrophilic surfaces. ica expression is modulated by various 
environmental conditions, appears to be controlled by SigB and can be turned on and 
off by insertion sequences (IS) elements. Recent studies have shown that S. aureus, 
like S. epidermidis, has the ica locus, which encodes the functions required for 
intracellular adhesin. These data suggest that the early stages in biofilm formation 
may be similar between these two organisms (35,63). Although it has been shown 
that ica has a role in adhesion for biofilm formation, however, it was not identified in 
our biofilm experiments. 
Bacterial pathogens that are primarily extracellular, such as S. aureus, can adhere to 
components of the extracellular matrix (ECM) of the host to initiate colonization. 
Adherence is mediated by protein adhesins of the MSCRAMM (microbial surface 
components recognizing adhesive matrix molecules) family, which in most cases are 
covalently anchored to the cell wall peptidoglycan (19). Different prototype 
MSCRAMMs such as fibrinonectin-binding protein A (FnBPA), a collagen-binding 
protein (Cna) and clumping factor A (C1fA) have been recognized in S. aureus. 
Fibrinonectin binding is a very common property of S. aureus isolates (53). 
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Proteins have been identified that are also involved in staphylococcal biofilm 
formation, such as the accumulation-associated protein (AAP), the clumping factor A 
(C1fA), the staphylococcal surface protein (SSP1), and the biofilm-associated protein 
(Bap)(37,63). An S. aureus transposon-insertion mutant has been isolated with a 
significant decrease in attachment to inert surfaces, intercellular adhesion and biofilm 
formation. The transposon is inserted in the bap gene, which encodes the novel cell 
wall-associated, 2276-amino-acid protein, Bap. The bap gene has been found in 5% 
of the S. aureus bovine mastitis isolates, but it was absent in the 75 clinical human S. 
aureus isolates analysed. All staphylococcal isolates harbouring bap are highly 
adherent and strong biofilm producers. In a mouse infection model, Bap is involved in 
pathogenesis, causing a persistent infection (37). 
Biofilm formation is thought to be a two-step process that requires the primary 
adhesion of bacteria to a substrate surface followed by the formation of multiple cell 
layers. In other words, at the first stage, the bacterium approaches the surface so 
closely that motility is slowed. The bacterium may then form a transient association 
with the surface and/or other microbes previously attached to the surface. This 
transient association allows it to search for a place to settle down. When the bacterium 
forms a stable association as a member of a microcolony, it becomes a three- 
dimensional biofilm structure (43,166). Studies have shown that teichoic acids, 
highly charged cell wall polymers, play a key role in the first step of biofilm 
formation by S. aureus. The cell surface of S. aureus, as in most bacteria, has a 
moderately negative net charge at neutral pH, which is probably due to the fact that 
the teichoic acids contain fewer positively charged D-alanine residues than negatively 
charged phosphate groups. Nevertheless, S. aureus can adhere to hydrophobic or 
slightly negatively charged surfaces such as polystyrene or glass, respectively. The 
direct interaction of bacteria and surfaces is dependent on van der Waals forces, 
which are generally attractive, and interionic forces, which can be either attractive or 
repulsive. Even if bacteria and surfaces are charged alike, van der waals forces can 
overcome repulsion and lead to adhesion (64). Figure 1.4 shows the events associated 
with bacterial adherence to biomaterials (4). 
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1.10 Aims of thesis project 
In recent years, the use of medical implants such as catheters, pacemakers, 
prosthetic heart valves, and joint replacements has increased dramatically. These 
devices can become colonised by microorganisms which form a biofilm consisting of 
a mono- or multilayer of cells embedded within a matrix of extracellular polymeric 
material. Release of microorganisms from the biofilm may initiate an acute 
disseminated infection. Implant-associated infections are difficult to resolve, because 
biofilm microorganisms are resistant both to host defence mechanisms and antibiotic 
therapy. The majority of implant infections are caused by Gram-positive bacteria, 
notably staphylococci. 
As the STM method has not been used for screening of bacterial virulence genes in 
biofilm so far, the main aim of this project was to find any probable new genes of S. 
aureus that are essential for biofilm formation by STM. In addition, it may be that 
biofilm formation and virulence are related, so we attempted to identify genes related 
in both processes. The general outline of the whole project is shown in figure 1.5. 
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Chapter 2 
General methods 
Chapter 2: General methods 
General methods are described here. For clarity more specific methods are 
described in their appropriate chapters. 
2.1 Isolation of Genomic DNA from S. aureus 
Method 1 
The bacteria were grown in 5 ml of Brain Heart Infusion (BHI) broth supplemented 
with erythromycin (20 Vg ml'). Erythromycin was added only for growing the 
mutants. One ml of overnight culture was removed under aseptic conditions and 
centrifuged in a microcentrifuge tube at 15,000 rpm for 1 minute. The supernatant 
was discarded and the pellet resuspended in 560 p1 of TE buffer. 5 µl of RNase (10 
mg/ml) and 5 p1 of lysostaphin (10 mg/ml)(Sigma) were added and mixed vigorously 
for 30 seconds. After 1h incubation at 37°C, 30 pl of 10% SDS, 5 p1 of RNase (10 
mg/ml), and 10 µl of proteinase K (10 mg/ml) were added and the incubation 
continued for an additional hour. Then 100 µl of 5M NaCl was added followed by 80 
p1 of prewarmed (65°C) 10% hexadecyltrimethyl ammonium bromide in 0.7M NaCl 
(CTAB/NaC1), and incubated at 65°C for 10 minutes. An equal volume of chloroform 
was added and the suspension mixed by vortexing. After centrifugation for 5 minutes 
at 15,000 rpm, the viscous upper phase was removed and transferred into a new 1.5 
ml microcentrifuge tube. The suspension was extracted twice with an equal volume of 
phenol/chloroform/isoamyl alcohol (25: 24: 1) and once with chloroform/isoamyl 
alcohol. The upper aqueous phase was transferred into a new 1.5 ml microcentrifuge 
tube and the DNA precipitated by adding 500 p1 isopropanol. After centrifugation at 
15,000 rpm for 10 minutes, the isopropanol was removed and the pellet washed with 1 
ml of 70% ethanol. The DNA pellet was air-dried and resuspended in 30 µl of sterile 
water (108). 
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Method 2 
The bacteria were grown in 5 ml of BHI broth supplemented with erythromycin (20 
µg ml"). After overnight incubation at 37°C the cells were harvested by centrifugation 
(10 min, 3000 g) and resuspended in 5 ml of SET pH 7.5, and then lysozyme to a 
concentration of 1 mg ml"' was added. After 0.5 h incubation at 37°C, 1/10 volumes 
of 10% SDS and 0.5 mg ml"1 proteinase K were added and incubation continued at 
55°C with occasional inversion for 2 h, when 1/3 volumes 5M NaCI and 1 volume 
chloroform were added and incubation continued at room temperature for 0.5 h with 
frequent inversion. The suspension was centrifuged at 4500 g for 15 min and the 
aqueous phase was transferred to a new tube using a blunt-ended pipette tip. The 
DNA was precipitated by adding 1 volume of isopropanol and the tube was inverted 
gently. The DNA was transferred into a microfuge tube, rinsed with 70% ethanol, air- 
dried and dissolved in a suitable volume of TE buffer (135). 
Method 3 
Chromosomal DNA from S. aureus was isolated using a Qiagen Genomic DNA Kit 
according to the manufacturer's protocol, except that the bacterial cells were lysed by 
lysostaphin (Sigma; 200 µg ml-) at 37°C for 30 minutes before DNA extraction. 
2.2 Plasmid DNA extraction 
Plasmid DNA from S. aureus and transformed E. coli was isolated using a Qiagen 
Plasmid Miniprep Kit according to the manufacturer's protocol, except that the 
staphylococcal cells were lysed by lysostaphin (Sigma; 200 µg ml") at 37°C for 30 
minutes before plasmid purification. 
2.3 Gel extraction 
Gel extraction of the PCR-amplified products was done using a Qiagen PCR 
Purification Kit and/or Qiagen QIAEX® according to the manufacturer's protocols. 
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Figure 2.1 Virulence gene identification from mutants with attenuated virulence 
a1 kb ladder (Invitrogen) was used as a marker. The gel was submerged in 
denaturation solution for 2x 15 min at room temperature. After rinsing with water, the 
gel was submerged in neutralisation solution at the same conditions. The DNA was 
blotted to a Hybond N+ membrane (Amersham) by capillary transfer, using 20x SSC 
buffer overnight. The membrane was UV-crosslinked at optimal crosslink (1200 
xl00µJ/cm2)( Spectro Linker, Spectronics Corporation) without prior washing. The 
procedure for hybridisation of the membrane was the same as described in section 2.4. 
2.5.2 Cloning of attenuated genes 
The rest of the digested DNA in section 2.5.1 was resuspended in ligation buffer 
(Promega) and self-ligated for 12-18 h at 16°C. The ligated products were transformed 
into E. coli XL1-blue, plated onto LB agar containing ampicillin and incubated at 
37°C overnight. A single amp` colony from each transformation was grown in LB 
broth containing ampicillin. Plasmid DNA was extracted as described in section 2.2. 
DNA flanking the transposon was sequenced using primer pseq-1 made against the 3' 
end of the transposon. 
2.6 Infection studies 
2.6.1 Preparation of bacterial inoculum 
To prepare a standard inoculum from S. aureus strain RN6390,0.5 ml of overnight 
culture was added into 50 ml BHI broth without antibiotics and incubated in a 37°C 
shaker. The OD600 was determined using a spectrophotometer at 15 minute intervals. 
When the OD = 0.7,50% sterile glycerol was added and aliquoted into one ml 
volumes immediately and kept at -80°C. The next day, vials Nos. I and 50 were 
thawed and cultured onto BHI agar plates after making a serial dilution of 10 fold of 
both. After overnight incubation at 37°C, viable count was done. As there was no 
significant difference between the viable counts of the two vials, all of the 50 vials 
were stored as a standard inoculum. 
A cryotube containing Iml of standard inoculum was removed and thawed quickly 
in 37°C water bath. 900 pl was removed and centrifuged at 13,000 rpm for 3 min. The 
supernatant was discarded and the pellet was resuspended in 900µ1 sterile PBS. 
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Colony forming units (CFU) were counted by carrying out serial 10 fold dilutions of 
bacterial suspension in PBS. 180µ1 of PBS was poured in 6 wells of a "U' bottom 96 
well plate. 20gl of bacterial suspension was added into the first well and mixed. Then 
20µl of this was placed into the next well containing PBS with a new tip. This was 
continued with a new tip each time until this has been done for a total of 6 times. 
Then an agar plate was marked into 6 sectors and 3x 20µl of the lowest dilution was 
spotted into one of the sectors. The same procedure was done with the remaining 
dilutions. Another plate was cultured with the same dilutions to give 6x 20µl spots 
per dilution. The plates were incubated overnight at 37°C. 
The colonies in the sector with more than 40 colonies per spot were counted on the 
following day. This is the number that is still easy to count (i. e. between 40 and 100 
colonies). The number of CFU per ml is achieved with multiplying the number of 
colonies by the dilution factor (83). 
2.6.2 Mouse inoculation 
To determine the number of bacteria required for mouse infection, and to see the 
duration of time required to recover the bacteria from the animals, a series of 
experiments was done. Different numbers of CFU of S. aureus strain RN6390 were 
injected intraperitoneally into the MF1 hairless mice (female, 6-8 weeks age) and the 
bacteria were recovered from the mice 24-72 hr after inoculation. Bacteria were not 
recovered from the mice that received less than 7x 106 CFU ml'1. The mice which 
received more than 9x 106 CFU ml-1 died between 12-18 hr after inoculation with no 
significant symptoms. We therefore chose a dose of 8x 106 CFU ml-1 at incubation 
time of 24 hr. 
A series of 25 pools of 33 mutants were used. Each pool contained 33 mutants with 
individual selected tags (see chapter 5 for details). For mouse inoculation, bacteria 
from each pool were washed twice with Bill broth by centrifugation at 4000 rpm for 
10 min and resuspended in BHI broth. The OD620 was determined using a 
spectrophotometer [OD620 of 1.6=109 CFU ml''] (27). The bacterial suspension was 
diluted to approximately 8x 106 CFU ml" and added to an equal volume of human 
serum (Sigma). This mixture (0.2 ml containing approximately 8x 105 CFU) was 
injected intraperitoneally into a MF1 hairless mouse (female, 6-8 weeks age). The 
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number of CFU in the inoculum was verified by viable count after plating a diluted 
aliquot of the inoculum onto BHI agar. Bacteria were recovered 24 hr after 
inoculation from spleens of animals as follows. 
Half of each spleen was homogenised in 1 ml of sterile PBS in a microfuge tube. 
Cellular debris was allowed to settle and 1 ml of PBS containing cells still in 
suspension was removed to a fresh tube and centrifuged for 2 min at 3000 rpm. The 
supernatant was discarded and the pellet resuspended in 1 ml of sterile PBS. A 
dilution series was made in. sterile PBS and 100 µl of each dilution was plated onto 
BHI agar containing erm (20 µg ml''). Bacteria were recovered from plates containing 
between 1000 and 4000 colonies, and a total of over 10,000 colonies were recovered 
from each spleen were pooled for DNA extraction (72). 
2.7 Biofilm formation 
The method for biofilm formation has been adapted from those used for Candida 
species with slight modification (13,69). Discs of catheter material (surface area, 0.5 
cm2) were cut from catheters, and sterilized by UV irradiation for 20-30 minutes each 
side. Silicone urinary Foley catheters from Vygon, UK were used. The discs were 
placed in wells of 24-well Nunclon tissue culture plates. Standardized cell suspension 
(80 µl) was applied to the surface of each disc, and the discs were incubated for 1h at 
37°C. Nonadherent organisms were removed by gentle washing with PBS. The discs 
were incubated for 24 h at 37°C, submerged in 1 ml of BHI with erythromycin (20 gg 
ml-1). Discs without cells were incubated in the same way as the control. After biofilm 
formation, the discs were removed from the medium and gently washed with PBS to 
remove nonbiofilm cells. Biofilm organisms were washed with 4 ml sterile BHI with 
erythromycin by vigorous moving of the container. The chromosomal DNA was 
extracted from the suspension. 
2.8 PCR 
DNA extracted from single bacterial mutants or pools of mutants was used as 
template for PCR experiments. The PCR was done in 50 µl reactions containing 
75mM Tris-HC1 (pH 8.8); 20mM (NH4)2SO4; 2mM MgCl2; 0.01% Tween 20; 0.2mM 
each, dATP, dCTP, dGTP, and dTTP; 1.25 U of Taq DNA polymerase (Promega); 
42 
400 ng each of primers P12 and P13; and 2.5 µg of target DNA. After initial 
denaturation of 4 min at 95°C, thermal cycling consisted of 35 cycles of 45 sec at 
50°C, 10 sec at 72°C, and 30 sec at 95°C. In some experiments, a Reddy-Load PCR 
Mix (Advanced Biotechnologies, Surrey, UK) was used at the same conditions. 
2.9 Labelling 
DNA extracted from single bacterial mutants or pools of mutants were used as 
templates for PCR to generate labelled probes. The PCR was done in 50 µl reaction 
volumes and subjected to a [digoxigenin (DIG)-11]-dUTP-labelling PCR using a PCR 
DIG Probe Synthesis Kit as described by the manufacturer (Boehringer Mannheim) 
and using primers P12 and P13. After initial denaturation of 4 min at 95°C, thermal 
cycling consisted of 35 cycles of 45 sec at 50°C, 10 sec at 72°C, and 30 sec at 95°C. 
2.10 Ethanol precipitation 
PCR products of labelled tags were precipitated with ethanol to concentrate the 
labelled tags and increase the efficiency of the digestion process in making the probes. 
1/10 volume of 3M sodium acetate pH 5.2 and 2.5 x volume cold absolute ethanol 
were added and kept on ice for 10 minutes after vortexing. The solution was 
centrifuged at 13,500 rpm for 15 minutes and the ethanol was discarded. 250 µl cold 
70% ethanol was added and centrifuged at 13,500 rpm for 10 minutes. This was done 
twice. All centrifugation was done at 4°C. The ethanol was discarded and the pellet 
was air-dried and 20 µl sterile water was added. 
2.11 Digestion of the tags 
To recover the tags without the arms from the PCR products, 2 µl of the 
concentrated labelled PCR products of single bacterial mutants or pools of mutants 
(section 2.10) was digested with Hind III enzyme at 37°C overnight. 1 µl (10 U) of 
Hind III enzyme (Life Technologies), 1µl of buffer, 2 µl of template and 6 µl of water 
were used in a 10 pl reaction. A total of 30-50 gl reaction was used for each sample to 
make enough labelled tags as the probes. After overnight incubation, the whole 
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digestion reaction was run in a 3% agarose gel electrophoresis, and the band of 40 bp 
was purified using a QIAEX II Kit according to the manufacturer's protocol. 
2.12 Gel electrophoresis 
Different percentages (0.7%, 1%, and 3%) of agarose gel were used to run the 
genomic and plasmid DNAs, digestion products of genomic DNAs for Southern 
blotting, and digestion products of labelled PCR products and probes respectively. 
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Chapter 3: Analysis of existing library of mutants 
The identification of virulence genes and infection mechanisms in bacterial 
pathogens can lead to new insights for disease-control strategies. Recently, 
methodologies have been developed that enable genetic approaches to be used for in 
vivo studies of bacterial pathogenesis. One of these new methods is signature-tagged 
mutagenesis (STM). We were interested to use STM in staphylococcal mouse 
infection and biofilm. A library of tagged insertion mutants of S. aureus strain 
RN6390 with inserted Tn917 transposon was generously provided by Professor 
David W. Holden, Imperial College School of Medicine, London, UK. 
3.1 Making the genomic DNAs 
Genomic DNA from S. aureus (as individual and pools of 96 mutants) was isolated 
by different methods. All protocols described in section 2.1. A typical result is shown 
in figure 3.1. 
3.2 Making the probes 
DNA extracted from single bacterial mutants or pools of mutants were used as 
templates for PCR to generate labelled probes. The PCR was done in 50 µl reactions 
and subjected to a [digoxigenin (DIG)-11]-dUTP-labelling PCR using a PCR DIG 
Probe Synthesis Kit as described by the manufacturer (Boehringer Mannheim) and 
using primers P12 and P13. After an initial denaturation of 4 min at 95°C , thermal 
cycling consisted of 35 cycles of 45 sec at 50°C, 10 sec at 72°C, and 30 sec at 95°C 
(see figure 3.2 for results). 
The PCR products (approximately 80 bp) were precipitated with ethanol and then 
digested with Hindlll (which cuts the signature tags within the modified transposon) 
at 37°C for 12-18 hr. The digested products (40 bp) were gel purified using a Qiagen 
PCR Purification Kit and/or Qiagen QIAEX® according to the manufacturer's 
protocols (figure 3.3). 
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Figure 3.1 Two genomic DNAs from different pools 
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Figure 3.2 PCR products from 4 different genomic DNAs 
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Figure 3.3 Three probes from different genomic DNAs 
3.3 Hybridisation experiments 
Probes were hybridised to nylon membranes according to the method described in 
the DIG Probe Synthesis Kit. For dot blot hybridisations, genomic DNAs (0.15-0.2 
Vg) were transferred onto a Hybond N+ membrane (Amersham). 
According to the literature (29,72,112), the probes should hybridise to the genomic 
DNAs of the tagged insertion mutants. When we hybridised labelled probes to 
chromosomal DNA of individual mutants, we were unable to generate a signal. 
Therefore, a series of experiments was done to compare hybridisation strategies. PCR 
products of the genomic DNAs and gel extraction of the PCR products were 
compared. Both methods had signals. The PCR products were chosen for future 
analysis. 
At the next step, artificial input and output probes were hybridised to the different 
membranes to check that the system worked properly. All of the experiments, except 
three, showed cross-hybridisation of the tags. We therefore undertook a detailed 
analysis of the existing mutants to determine whether we could use the library. The 
results are summarised in table 3.1. 
Experiment series 1: 4 random mutants were deleted from a pool of 96 mutants to 
make an artificial output probe of 92 mutants. The result showed signals from all 96 
spots suggesting 4 signals with the deleted mutants on the output membrane. In a real 
experiment this would suggest no loss of mutants. 
Experiment series 2: The experiment in series 1 was done in another way. 4 
random mutants (different from the deleted mutants in experiment 1) were deleted 
from a pool of 94 mutants to make an artificial output probe of 90 mutants. The result 
showed loss of 2 out of 4 mutants. In other words, 2 out of 4 mutants were not 
detected. 
Experiment series 3: The experiment in series 2 was done in another way. 4 probes 
were made from the 4 deleted mutants and then each probe was tested with input 
membrane of 94 mutants separately. The 4 mutants were A6, D4, F9, and H8. The 
mutants D4 & H8 showed no cross-hybridisation on the output membranes that 
contained 94 mutants. But mutant A6 had a cross-hybridisation with one mutant (A5), 
and mutant F9 had cross-hybridisation with 3 mutants (E12, G6, and G7). In other 
words, the cross-hybridisation results in the previous experiment were confirmed. The 
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results in the experiments series 2&3 were also confirmed by sequencing the tags 
(discussed in chapter 4). 
As the first three experiments showed there was a problem with the hybridisation, a 
more detailed set of experiments was done. 
Experiment series 4: A probe from one mutant was hybridised to an artificial input 
of 10 random mutants. As expected there was just one signal on the membrane 
(Figure 3.4). According to the expected result in this series, we decided to do a series 
of hybridisation experiments on a pool of 10 random mutants. 
Experiment series 5: The experiment in series 4 was repeated ten times with the 
same mutants, and one mutant was chosen to prepare the probe each time. The results 
showed that two mutants (Nos. 5& 9) had cross-hybridisation with each other (Figure 
3.5). The details of this series are shown in Table 3.2. 
Experiment series 6: This experiment was done on a pool of 10 random mutants. 
The random selected mutants in this series were different from the 10 mutants in 
series 5. Mutants Nos. 3&9 were deleted to make an artificial output pool with 8 
mutants. Probes were made from the 10 mutants as the input and from the 8 mutants 
as the output pools. Hybridisation experiments were done with both input and output 
probes. As it is shown in figure 3.6, there were just 8 expected signals on the output 
membrane. In other words, there were no signals with the 2 deleted mutants in output 
probe. 
Experiment series 7: As we had the expected results in series 6, the same 
experiment was done on a different series of 10 random mutants. In this experiment, 9 
signals were seen instead of 8 expected signals on the output membrane. 
Experiment series 8: The probes from the two deleted mutants in series 7 (with 
cross-hybridisation) were hybridised with input membranes of 94 mutants 
individually. The 2 deleted mutants were B5 & D2. The results showed that one 
mutant (D2) had just one expected signal, but the other (B5) had cross-hybridisation. 
In other words, mutant B5 had 2 signals, but D2 had no cross-hybridisation, both on 
the membrane of 94 mutants. 
Experiment series 9: A pool of 8 random mutants was chosen. Mutants Nos. 6&8 
were deleted to make an artificial output pool with 6 mutants. Probes were made from 
the 8 mutants as the input and from the 6 mutants as the output pools. Hybridisation 
experiments were done with both input and output probes. As expected, there were 
just 6 expected signals on the output membrane (Figure 3.7). 
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Figure 3.4 Hybridisation of the membrane of 10 mutants with the probe No. 6 that shows 
expected result. 
(a) 
(b) 
Figure 3.5 Hyhridisation of the same membrane of 10 mutants with the probes No. 5 (a) and No. 
9 (b). As seen there is also a strong signal (cross-hybridisation) with mutant No. 9 in (a) and with 
No. 5 in (b). There is also some cross-hybridisation with mutant No. 4 in both membranes. 
(a) 
+ve control -ve control 
(b) 
+ve control -ve control 
Figure 3.6 Hybridisation of the same membrane with probes of 10 mutants as the input (a) and 8 
mutants as the output pools. Mutants Nos. 3&9 have been deleted to make an artificial output 
probe. The experiment showed expected results. There are 10 and 8 signals on the input (a) and 
output (h) membranes, respectively. The two deleted mutants (Nos. 3& 9) showed no signals on 
the output membrane (b). 
}k:.. ý: 
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Figure 3.7 Hybridisation of the same membrane with probes of 8 mutants as the input (a) and 6 
mutants as the output pools. Mutants Nos. 6&8 have been deleted to make an artificial output 
probe. The experiment showed expected results. There are 8 and 6 signals on the input (a) and 
output (b) membranes, respectively. The two deleted mutants (Nos. 6& 8) showed no signals on 
the output membrane (b). 
The details of the experiments on the existing library are shown in table 3.3. 
To test the library of mutants and hybridisation process, a series of artificial input 
and output probes were hybridised to the different membranes (tables 3.1,3.2, and 
3.3). The results showed that all of the experiments, except three, had unexpected 
cross-hybridisation. 
The experiments on the existing library that were done in different scales could be 
divided into 2 distinct groups. The first group includes series 4,6,9, and parts of 
series 3 and 8 that showed no cross-hybridisation and only expected signals were 
seen. The second group includes series 1,2,5,7, and a part of series 3 and 8 that 
showed cross-hybridisation. As we had some expected results, it showed that the STM 
method worked properly, and the cross-hybridisation in some experiments is probably 
because of a problem with the library. 
3.4 Conclusion 
The hybridisation experiments on the existing library took more than one year. 
The results showed that the library was not reliable for cross-hybridisation free 
experiments. There are at least 3 possible reasons for this problem, (i) the problem 
with hybridisation itself, (ii) incomplete removal of the arms of the tags in the process 
of digestion and making the probes, and (iii) contamination of the tags. The first 2 
possibilities are excluded as they are not supported by some series of experiments, 
and as results showed the method does work in some experiments. It is therefore 
concluded that the problem was more likely the contamination of the mutants with 
each other or original tags used to make the library. This could have occurred in the 
first inoculation from the master plates (which contain all the representative tags in 
each plate) to the cryotubes. 
As the existing library of mutants showed unexpected cross-hybridisation, the whole 
library was discarded. We next tried to use the selected tags in plasmids of S. aureus 
strain RN6390 for future experiments that will be discussed in details in chapter 4. 
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Experiment 
series 
No. of 
mutants on 
the membrane 
No. of 
mutants 
present in 
the robe 
Result 
(unexpected 
signals) 
Deleted mutants 
1a* 96 96 - 
92 4 
1b* 96 96 - 
92 4 
2 94 94 - 
90 2 
3a 94 94 - 
90 2 A6, D4, F9,118 
3b** 94 1 (A6) 1 AS 
1 (D4) - 
1 3 12 GG G 
18 - 
4 10 1 - 
1 o. 1 - 
i o. 2 - 
1 No. 3 - 
1 o. 4 - 
5 10 1 o. 5 1 
1 o. G - 
1 No. - 
1 No. B - 
1 No. 9 1 
1 (No. 10) - 
6 10 10 - 
8 - Nos. 3&9 
7a*** 10 (pooled) 10 - 
8 1 BS D2 
7b*** 10 (mixed) 10 - 
8 1 BS D2 
94 - 
8**** 94 1 (B5) 1 
1 (D2) - 
9 8 8 - 
6 - 
Table 3.3 Details of the results of hybridisation experiments with existing library of mutants 
* Two different series were tested. 
** The same series of mutants in the experiment 3a were tested. Individual probes were made 
from the mutants which had cross-hybridisation in the experiment 3a. 
*** The same series of 10 mutants were tested twice. In the first experiments, the probes were 
made from a pool of 10 and 8 mutants as input and output pools respectively, but in the second 
one, probes were made individually and then mixed up. 
**** The deleted mutants in experiments 7a and 7b were examined with a membrane with 
larger number of mutants. One of the mutants showed cross-hybridisation with another mutant 
which was not present in the experiments. 
Chapter 4 
Analysis of selected tags in plasmids of strain 
RN6390 
Chapter 4: Analysis of selected tags in plasmids of strain RN6390 
Plasmid pID408 (Figure 4.1) has been constructed for mutagenesis of S. aureus 
strain RN6390 in Professor David W. Holden's laboratory. The amp1/ori/rop region 
from plasmid pBR322 allows replication and selection of the plasmid in Escherichia 
coli, while the temperature-sensitive replicon (pE194ts) and the cm` gene of pTV32ts 
permit replication and selection in S. aureus at 32°C. The DNA signature tags have 
been incorporated in the EcoRl site of transposon Tn917. A series of 96 plasmids 
carrying different tags has been separately transformed into S. aureus strain RN6390. 
The plate containing of 94 of the 96 was sent to us by Professor Holden, and 
designated the master plate. This was used for all subsequent mutagenesis of S. 
aureus. 
A duplicate of the above master plate was generously provided by Professor 
David W. Holden, Imperial College School of Medicine, London, UK. 
4.1 Preparation of plasmid from S. aureus 
Plasmid DNA from S. aureus strain RN6390 which had the selected tags (94 
strains) was isolated as described previously in section 2.2. Plasmid DNA was 
successfully isolated at good concentration (Figure 4.2). 
4.2 Hybridisation with probes from S. aureus plasmids 
Probes were made as described in section 3.2. Probes were hybridised to nylon 
membranes according to the method described in the DIG Probe Synthesis Kit (Roche 
Diagnostics GmbH, Germany). For dot blot hybridisations, 0.15-0.2 pg plasmid 
DNAs were transferred onto a Hybond N+ membrane (Amersham). Artificial input 
and output probes were hybridised to the different membranes to confirm the system 
works properly. Cross-hybridisation was seen in the most of the experiments, which 
were done with the probes from plasmid DNAs. 
A series of experiments was done to check whether the selected tags in plasmids of 
strain RN6390 were suitable for a work of free cross-hybridisation. The hybridisation 
experiments on the selected tags in plasmids of strain RN6390 took more than one 
year. 
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Figure 4.1 Construction of the vector pID408 (b} courtesy of Prof. hol(len) 
12 kb 
10 kb 
1 2 1 kb 3 
Figure 4.2 Plasmid preparation from 3 S. aurcus strain RN6390 
Experiment series 1: As there was a lot of cross-hybridisation in experiments with 
genomic DNAs from the existing library, the first two experiments with the selected 
tags in plasmids of strain RN6390 were done on a small scale. Four strains (A2, A3, 
A4, and A5) were chosen randomly. Probes were made from strains A2 and A5 and 
hybridised to the same membranes of the 4 plasmids. Results showed that the probes 
did not detect just the expected strain. In other words, there were 2 signals instead of 
one on each membrane. 
Experiment series 2: This experiment was repeated 4 times. 4 probes were made, 
and one different probe was hybridised to a membrane of 94 plasmids each time. 
Again, the results showed that none of the 4 probes could detect the expected strain on 
the membranes. The probes which were used in this series were the same 4 plasmids 
in series 1. This experiment showed that plasmids A2 and A5 had actually more than 
one signal when hybridised to a large number of plasmids. 
Experiment series 3: The experiment series 1 was repeated 4 times with another 
different series of 4 plasmids. The 4 selected strains for this experiment were A6, A7, 
A8, and A10. The results showed that none of the 4 probes could detect just the 
expected strain on the membranes. In other words, there was more than one signal on 
each membrane. 
Experiment series 4: In this series, a probe was made from strain B3. The probe 
was hybridised to 8 random plasmids including B3. The result showed that the probe 
could not detect just the expected strain, and another signal with strain B2 was also 
seen on the membrane (Figure 4.3). 
Experiment series 5: In this series, a probe was made from strain E7. The probe 
was hybridised with 8 random plasmids including E7. The result showed that the 
probe could detect just the expected strain on the membrane. In other words, there 
was just one signal on the membrane. 
Experiment series 6: In this series, the 2 strains in series 4 and 5 were checked 
with an artificial pool with a larger number of plasmids to check whether the above 
results could be confirmed. 2 probes were made from strains B3 and E7, and 
hybridised to an artificial input of 16 random plasmids including the 2 strains on the 
same membranes. The results showed that one membrane had just the expected signal 
(E7), but the probe B3 could not detect just the expected strain, and another signal 
with strain B2 was also seen on the membrane. 
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Figure 4.3 Hybridisation of 8 plasmids with a probe from 
No. 4. There was an additional signal 
with plasmid No. 8. 
Experiment series 7: In this series, the strains B3 and E7 were checked with all of 
the 93 plasmids. 2 probes of the strains B3 and E7 were hybridised with a pool of 93 
plasmids individually. The result showed that the strain E7 had no cross- 
hybridisation, and only one expected signal was seen on the membrane. However, 
there were 3 signals on the membrane B3 rather than the one expected signal; the 
other two were unexpected cross-hybridisations with strains B2 and F7. 
The experiments in series 4,6, and 7 showed that strain B3 could not hybridise free 
of cross-reactions, whereas the experiments in series 5,6, and 7 showed that the strain 
E7 could hybridise clearly. 
The results of the experiments with the selected tags in plasmids strains RN6390 are 
summarised in table 4.1. 
4.3 Transformation into E. coli 
Due to the cross-hybridisation found in the experiments with plasmid DNAs, it was 
decided to transform all of the plasmid DNAs from S. aureus strain RN6390 into 
suitable competent E. coli cells. More DNA was needed to test the tags, and this was 
not feasible using S. aureus strains. 93 out of 94 plasmids were transformed into XL1 
blue cells (Stratagene). One sample was not successfully transformed even after 
several attempts. 
4.4 Hybridisation with probes from plasmids generated from E coli 
Plasmid DNAs from 93 transformed cells was isolated as described in section 4.1, 
except using lysostaphin. Probes were made as described in section 3.2 and 
hybridisation was done as described in section 4.2. Cross-hybridisation was seen in 
some of the experiments, which were done with the probes from plasmid DNAs from 
the transformed cells. Therefore, there was a problem with hybridisation of plasmids 
as isolated from E. coll. It was therefore decided to check any possible identity 
between the tags. Plasmid DNAs of a series of the strains showing cross-hybridisation 
were therefore sequenced. 
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4.5 Sequencing and selecting of non-cross hybridising tags 
4 plasmid DNAs from experiments series 4-7 were subjected to sequence analysis. 
The above experiments showed that strain B3 cross-hybridised with strains B2 and 
F7, but strain E7 did not cross-hybridise with any of the 93 plasmids. The results 
showed that the sequences of 3 tags B2, B3, and F7 were exactly the same (Figures 
4.4 & 4.5), whereas the sequence of tag E7 was different from the others. The result 
of sequencing therefore confirmed the hybridisation experiments. 
As 3 of 4 plasmids were found to contain similar tags, it was decided that all of the 
94 plasmids should be sequenced. 84 out of 94 plasmids were sequenced. The results 
showed that 51 strains had more than 50% similarity between the tags, and therefore 
were not suitable for a cross-reaction free hybridisation. The 33 tags with no more 
than 50% identity were chosen for future experiments (Figures 4.6-4.9). To check 
whether the system worked properly, a series of 10 random mutants were chosen and 
artificial input and output probes were hybridised. The results showed no cross- 
hybridisation. As shown in figure 4.10, there were good signals with all of the 10 
mutants in the input membrane (a). In membrane (b), two random mutants (Nos. 2& 
9) were deleted and a probe was made from the remaining 8 mutants. There were still 
good signals with the 8 mutants, but not with numbers 2 and 9. In the third part of the 
experiment, 5 mutants (numbers 2,4,6,8, and 9) were deleted and a probe was made 
from the remaining 5 mutants. There were still good signals with the 5 mutants, but 
not the deleted ones. 
In another experiment, all 33 selected tags were checked. All 33 gave good signals 
in the output membrane (Figure 4.1 1)(a). In membrane (b), 4 random tags (Nos. 11, 
20,21, and 29) were deleted and a probe was made from the remainder 29 tags. There 
were still good signals with the 29 tags, but not the deleted ones. 
It was therefore concluded that the 33 selected tags had no more than 50% identity 
and were suitable for cross-hybridisation-free experiments. 
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- Elp  + 
® Consensus 
84 Sequences 
tag A2 
tag A3 
tag Al 
tag AS 
tag A6 
tag A7 
tag A8 
tag A9 
tag A10 
tag All 
tag A12 
tag 31 
tag 32 
tag B3 
tag 34 
tag 35 
tag B6 
tag B7 
tag Be 
tag B9 
tag B10 
tag 312 
tag Cl 
tag C2 
tag C3 
tag Cl 
tag C7 
tag C8 
tag C9 
tag C11 
tag D2 
tag D3 
tag D4 
tag D5 
tag D6 
tag D7 
tag D8 
tag D9 
tag D12 
10 Pos=3 
AGAGCGCGCGCGCGAGCTCGCGCGCGCGCTCGCTCCCGCTX{ 
i0 2a 30 4a 
T'TýGýGCý; T; GGHi: Hi_ ; 'I'I1'. 'ý{i; rjýj`j1; ý F{f; G 
GGCGAGTGAGGG'IT= TATTGGm; GCTGGCGG'IVT: GATI'fiT 
AGTTGAGZGAGTGTGCGCGCGCTCGGGAGGGTGTGGAACCG 
AACAAACAACACAGACCACCATIHGCTPCACTCCAGCGCC 
AACAAACAACAC'AGACCACCATAGCTCACTCCAGCGCC 
ACCGCACACRCTCACCCTATCCCTCGAACAACACCCCCCC 
CGAGTTCGGGGWýGATP-ýGTTTTGTTCTCGCGATAT 
CGGT= GCGCGGGTIGGGGTgGGTGTGGATTTPIC'TGTGTTG 
CGAGTPGGGGGTI'GGATGGTI'TI~_ TICT'GCiGAW T 
ACACCGCCCACAACCAGCTCCAACTD_CACAZCG 
ATI'qGCAAr_. CGCAATIC'CAGCCCGACCGC'ICCCGCCCAACCC 
CCCTCCCGAC. CGACC'XCAI'AI'CAATIAACT"ICT: AAGAi' 
ATMCCACACCCGCGATCACGCACAAAACCCCGCCCCCTICG 
ATIACCACACCCGCGATCACGCACAAAACCCCGCI'CCCRCG 
AGGGCGCGTP: GCGGTCTCGGTGGTIGGAGATIr= T= GAGGT 
CCAACGATßACCCCCGCCACCGCAAGCCCT'ACAACAGCA 
AGGGTGT*I1RGCIn: GATC4 GTGC'IGGAGCGCGCGCG TDGGAT 
G'IY'GAGGGAGZGCGATPDCGGTG'PGGGGGGGGTGGCN G" 
GTCGAGGGAGTGCGRTTTCGGTGTGGGGGGCTGGCTAGCT 
1-GATC7lG'IGGGCWGGGATCGTi'IG7GAGCGTGGTTGGG 
AGGTAGCGCGr_, GAGTTGGTMGCTAGTTATCGTGGGTG 
CACGAACTAACCATCCC'RAi'ACCCACCAA'iCTCCCAAACr. 
Ra4GCGCTCTAGGGAGTTAGCGGTG GCGGTCGGGATGTGT 
AGCTAGi: G'IGCGCGRGCCi; TIGGGC74_ TAGCGGTTGTGTT 
i: GAG7Gi: 'P: GAGGTAGCTCGGGTGGGGGCTGGATATATCG 
i; GAGTGGTGGAGGTAGCTCGGGTGGGGTCTGGATATATCi' 
RACGCACGAGAC_. CGACCCCGCCCACTAACGCTCCATCCCT 
GAGT= GTGGAGGTAGCT'CGGTGGCGTCTG GATATa'r_, 
AGAGGGGGCGAGCTAGTGCGAGCGCGTIIACTGGGTGTTG 
CGAT: GGGCTTGCGGGGGGGGGGTDGGTTTr; GCTCTCGGG 
GGAGATATCGCTGGTGTCAGCGCGAGTGAiGAT: GGGGGAG 
CGGGCGGTCGCTCGATTTGTCGGGGTGGTTCGCCCGATGT 
ACAACTATAACGCACCATACCCCCACAACCAACCACACCC 
AGGTCGGGCGCTACGGCGGTACTTTGGGCGCTTTAr, GTTT 
AGCGGGTTCTGTCGCGAGGGGTGTTTGGATGGTGTGTGAG 
AGCGTGGTl'MGTTAGTICGCTrýTTGGGCGT'IIAGTGAGGT 
AGACACCCCGCCCTAACAACAGCTCCACTCTACCTACCC 
,; GAGRGGTGGAGGTAGCTCGGGTGGGGRCTCGATATATCG. 
CGA4x1ACCCAAACCCGCCCTATAGCTC7CCCCCGCACACC 
Figure 4.6 Alignments of the 84 tags using the MegAlign program of DNASTAR 
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CTCGATAAA'1CAACAI-ATCCCACGCGCCACCGCC CCC9HT 
i: W, GCTAGCGCGCGTGT. GTGGGGATCGGGGGGGAGCGAT 
AAACATaACGAGCCCGCCCCACCGACAGCGAGCCATCGCA 
GGCGCGGGTGGGATGG77MGGCGATZ'1RGTTITIGATrjT 
GTGGGGGGAG7I1aGGGCGCGATTGGGTPGTTG'I'DG7CGGG 
AAGACGCCATATCCCCCACTACATCTCTATCACGCCAGCA 
AGAGCCCGCACACAAGCCATCCAACCAAACCGGTCGATCC 
CTCACCACCCAGCGCCAGCAACCGCCAGCCACCTAGCACT 
AAGACGCCATATCCCCCACTACATCTCTATCACGCCAGCA 
ATGGAGAGCGAGAGGGGGAGGTGTCGTGGGAGAGCGTGGT 
GGGGGGAGGTGGGGATGT7GAGTTGGTGATAT3TCGTGGG 
ACCGCAATRCCAAGCGCTACCCAT:. GCGCTAGACCCACCT 
ACCGCAACCACACCACTCCCCGAGCGCGCCCCCCACAG 
CGATCCACCTCCCTCCATATACCACCCGATCTAACCACCT 
CGATCCACCTCCCTCCATATACCACCCGATCTRACCACCT 
ACCGCAACCACACCACTCCCCGAGCGCGCCCCCCACAG 
AGGTGGAGCGGGTTAGTGCGAGGTAGCTAGTTCGCTTPIT 
CACTCCAGCGTCCCCCCGCGACAAAGCGAGACRARCCCRT 
A'iYiCCACACCCGCGATCACGCACARRRCCCCGCCCCCTCG 
RGAACTRACCAGCACCAACCACTATCCCARCACCGCC 
ACCGCARTACCRAGCGCTACCCATCGCGCTAGACCCACCT 
TTGGCGCGGGGGG'IIiRGTTTTGCRGGCTGGGGAGGGGTCT 
AGCACAACATCACCATCCCACCAGCTCTCGCGCGCTCGCC 
CTCGAGCGGTAGATGGCGAGGGGGAGAGCTCGGTAGGTC: T 
CAAAAGCGCACACGCCCCCGCAATA'Ix1CCCC'I'CACCCGCC 
CAAAAGCGCACACGCCCCCGCAATATACCCCTCACCCGCC 
RTCGCCACACACCRRCAAACATrlATTCGCTACATCCCACT 
ACAACACACGCCCCATACATCCAGCCCGCGCACTCACG 
ACCGCAATACCAAGCGCTACCCATCGCGCTAGACCCACCT 
ACCGCAATACCAAGCGCTACCCATCGCGCTAGACCCACCT 
RACCCAAAACACATA'ilaACACCCACTCACGCCATAACGCC 
C'IGGCACTaCCAGCACGATCCCCATACCCCCCAAACWT 
ATCAAAAGAAAGACACAAAGCCCGCTATCCCTCGCGCCCT 
GGpGAGGGTGTGTGTGTGGGGTCTCTATCTCGTTCTAGTG 
CTAGGCGTGGGRGAGAGAGCGGGTTCTAGTTTGTGAGGG 
ACCGCACACCACCAAGAACTCTCTCGCTCCCTCTCGCTCC 
ATGTGGTGGTGGAGCGCGATGGTGCGGGTGCTGTCGGTTT 
ACRTCTAACCCCCAAGCAAACACACCCGCACGACCTaTCT 
TGAGGTAGGGCGRTGTGTTTIGGGTICGTGATMTCGGT 
TGAGGTAGGGCGAGGTGTTI'IGGGTPCGTGATTTCTCGGT 
AAACCGCCACAAATCTCTCGACAGCTCTCGCCCCCTAACGI"' 
CCCGCTRGCCACCGAGACCTCCCTRAAGCGCCCACCCT;, T 
ATCCCTRACCCCCCCCAACTAACGACCAATCTCGACCACC 
RGCCAACACAATaTCTaCCTATAACACCAGCTCCCACT'G 
CTTGGTPPGGAGCTCGGG 
Figure 4.6 (continued) 
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10 20 30 40 50 CTAG---- G GTGGGAGAGAGA--GCGGGTTCTAGTTRGTGRGG - GAAG 
AGTG---- GTGRGTGTGCGCGC--GCT CGGGAGGGT GTGGAAC-CGAAG 
CGGT----- GGCGCGGGT6GGGT--AGGTG'IGGRT'ITTMT GTGT 'GR AG 
CGAG-- -- TCGG GG'IrAA--T GGTTTIGT'lY''P'GCGAT TA AG 
CTRG - GART -GGAATIC CAACCTCAAGCTI? IGGGGG iii' 
AGGG----- TGTTAGGTGGATG --GTGCTGGAGGGCGGGGGTTGG TA AG 
GTCG---- GGGAGTGCGATTTC--GGTGTGGG GGGC7GGC7'RGC-1'AA G 
CGAT---- R"IGTGGGGTAGGGR--TGGTR'IGTGAGCGTGGTTGG - GAAG 
AG---- TAGCGCGGGAGTIG--GTRGGCTRGTTATCGTGGGT - GAAG 
A G---- GGRL""'GGGGGAGRGC--GAT TGTG CTGTGGTTCGGG-TGC G 
AT ----- GGCGC'1ý'TRGGGA--GTRIAGCGGTGGCý=i: 'I~'GGGAT TGTAA 
AG -- GGGTGCGCGTGCGG--TTGGGCTGTAGCGGTTG T TTAAG 
AGAG---- GGGCGAGCRPGTGC--GAG CGCGTMCT G GGTGT-TGAAG 
GRTG----- GGGCTRL'. CGGGGG --G GGGTTGGTTIGGGCTGT-CG GG 
GGAG---- T9'PCGCTGGTG'1GR--GCGCGRGTGRGRTPrjGGGGGA - GAAG 
CGGG-- --GGTCGGTCGATTPG--TC GGGGTGGTIY'GCGCGAT TA AG 
AG G-- --GGG GCGCTRGGGC--GGTXIGTTIGGGCGCTTPRGGT- TT 
AGCG----- GGTIL'TGTCGCGA --GGGGTGTTTGGRTGGTGTGTG GA AG 
AGCG---- GGTTTIIRGTTAGTPC--GCTGTTGG GCGTTAGTGAGG-T ARG 
GGAG---- GGTGGRGGTRGCTC--GG GTGGG GTP'TGGATqTSaT-CGAAG 
GTGG-- GCGCGCGTGTGGTG--GGGAT'GGGGGGGAGC GAT AG 
GGCG-- --GGGTGGGATGGTPT--GGGCGRTTTAGTTTTTGATGT- A AG 
GTGG-- --GGGRGTTRGGGCGC--GATPGGGTTGTTGTP3TCGGG- A AG 
ATGG---- GAGCGAGAGGGGGR--GGTGTCGTGGGAGAGCGTGGT AG 
GGGG----- GGAGGTGGGGRTGT--TGRGTPGGTGATATGTCGTGG-GR AG 
AGGT---- GRGCGGGTTAGTGC--GAGGT1ßGCTAGTRCGCTTT -TPAAG 
TTGG----- CGCGGGGGGTATGT--TTTGCTGGCTG GGGAGGGGT TA AG 
T ----- AGCRCAACATCAC TCCCACCAGCTCTCGCGCGCT GCCAA 
CTCG---- GCGGTIRGATGGCGA--GG ---GGGAr_, AGCTCGGT GGTGT 
GGAG---- GGGTGTGT GTGT--GGGGTCTCTRTCTY'GTIICTAG-TGAAG 
AT G-- --GG TGGT+GGAGCGC--GATGGTGCr, GGTGCTGTCGGT TA AG 
TGA -----GGTAGGGCGATGTG--TTTIGGGTT'GTGATTTCTCG TA AG 
CTTG GAGCTCGGGAAGCT ' G4'TAGAATGGAATTCTACAAG TCAAG 
Figure 4.8 Alignment of the 33 selected tags using the MegAlign program of DNASTAR 
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Figure 4.9 Phylogenetic tree of the 33 selected tags using the MegAlign program of DNASTAR 
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Figure 4.10 Hybridisation of the membranes of 10 random mutants from the 33 selected 
tags. The membranes were hybridised with the probes from the input pool (a) and the 2 
different output pools (b & c). Hybridisation signals from mutants Nos. 2&9 in (b), and 2, 
4,6,8 and 9 (c) are present on the membrane with the input pool but not on the membranes 
with the output pools. 
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Figure 4.11 Hybridisation of the membranes of the 33 selected tags. The membranes were 
hybridised with the probes from the input pool (a) and the output pool (b). Hybridisation signals 
from tags Nos. 11,20,21, and 29 are present on the membrane with the input pool but not on the 
membrane with the output pool. 
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We were now in a position to use the 33 selected tags to construct a new library. To 
generate a new library of mutants, 20 µl of bacterial suspension from each of the 
selected wells containing 33 non-cross-hybridising tags of the master plate of S. 
aureus strain RN6390 were cultured into the wells of a second microtitre dish 
containing 180 gl of BHI and erm (20 µg ml"). After overnight incubation at 43°C, 
bacteria from each well were streaked on BHI agar containing erm and incubated at 
43°C overnight to obtain single colonies. Approximately 30-50 different erm1 colonies 
from each well were transferred onto BHI agar containing cm (20 pg ml-1) and 
incubated at 32°C, and onto BHI agar containing erm and incubated at 43°C, to screen 
for cros colonies. The agar plates were incubated overnight. Ern` cros colonies should 
lack the plasmid and carry a chromosomal insertion of Tn917. Individual erm` cros 
colonies from each of the 94 wells were transferred into corresponding wells of a third 
96-well microtitre dish containing Bill broth and erm. After overnight incubation at 
43°C, mutants were transferred to a fourth microtitre dish and grown at 37°C before 
use as inoculum. Mutant pools were also stored at -80°C in 50% glycerol. A series of 
25 pools of 33 mutants were used. Each pool contained 33 mutants with individual 
selected tags. The total number of mutants made was 33 x 25 = 825. 
To verify that the constructed mutants lack the plasmid and carry a single 
chromosomal insertion of Tn917, chromosomal DNA samples from two random 
individual mutant strains that had been cultured separately were digested with Hind 
III (which cuts the signature tags within the transposon) and then subjected to 
Southern analysis using a 723bp PstI A1wNI fragment of pBR322 containing part of 
the (3-lactamase gene as a probe to determine the size of the DNA fragment carrying 
this part of the transposon. The fragment of pBR322 was obtained by PCR using 
primers P21 and P22. The digested DNA was run in the 1% agarose gel, and a1 kb 
ladder (Invitrogen) was used as a marker. The gel was submerged in denaturation 
solution for 2x 15 min at room temperature. After rinsing with water, the gel was 
submerged in neutralisation solution at the same conditions. The DNA was blotted to 
a Hybond N+ membrane (Amersham) by capillary transfer, using 20x SSC buffer 
overnight. The membrane was UV-crosslinked at optimal crosslink (1200 
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xlOOiJ/cm2)( Spectro Linker, Spectronics Corporation) without prior washing. The 
procedure for hybridisation of the membrane was the same as described in section 2.4. 
As the mutagenesis is random, it is expected that the hybridising fragment in different 
mutants has a different size. For each of two separately analysed mutants, a single 
hybridising fragment of different size (6 and 8 kb) was observed (figure 5.1). The 
different sizes of the DNA fragments therefore confirmed that the mutagenesis was 
random. 
To verify that there was no cross-hybridisation between the mutants of the 
constructed library, a series of 8 random mutants was chosen and subjected to 
hybridisation. As shown in figure 5.2, there were good signals with all of the 8 
mutants on the input membrane. For output membrane, 2 random mutants (Nos. 6 and 
8) were deleted and a probe was made from the remaining 6 mutants. As shown, there 
were still good signals with the 6 mutants, but not the deleted ones. 
5.1 Phenotypic analysis of mutants 
To determine that mutagenesis had occurred randomly across the genomic DNA of 
the mutants of the constructed library, one of the known phenotypic characteristics 
was traced. Catalase production was chosen for this purpose. Different toxic forms of 
oxygen are produced as inadvertent by-products during the reduction of 02 to H2O in 
respiration. These reactive oxygen intermediates have many deleterious effects on 
living organisms, ranging from DNA strand damage to peroxidation of membrane 
lipids. Bacteria have evolved enzymes that destroy toxic oxygen products. The most 
common enzyme in this category is catalase, which attacks hydrogen peroxide 
(H202)(80) 102). All the mutants of the constructed library were therefore tested 
individually for catalase production. 
5.1.1 Catalase enzyme 
All staphylococci produce catalase, which catalyses the conversion of toxic 
hydrogen peroxide to water and oxygen. Hydrogen peroxide can accumulate during 
metabolism or after phagocytosis (118). Hydrogen peroxide is produced by bacteria in 
aerobes and facultatively either by a nonenzymatic reaction of oxygen with reduced 
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Figure 5.1 Southern hybridisation analysis of Tn917 insertions in the S. uureus genome of 
constructed library of mutants. The lanes (a) are hybridising fragments with different size from 
individual mutants. Lane (b) is I kb marker. 
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5; x 
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Figure 5.2 Hybridisation of 8 random mutants from the constructed library. Mutants Nos. 6 
&8 have been deleted to make an artificial output probe. 
flavoproteins or by enzymatic action on the superoxide radical. Hydrogen peroxide is 
a highly reactive molecule that can damage cell components. 
5.1.2 Catalase test 
When a drop of 3% hydrogen peroxide is placed on a culture, bubbles of oxygen gas 
will appear from the bacteria producing catalase. If no catalase is present, no bubbles 
will form. The test may be performed on growth transferred to a slide, or to an agar 
slant. The culture to be tested should be grown on nutrient agar. If the culture is 
grown on blood agar, and the sample gathered from the blood plate, there may be a 
false positive reading due to the reaction of hydrogen peroxide with blood. 
5.1.3 Results 
All the mutants of the constructed library were tested individually for catalase. The 
results showed that 1 out of 825 mutants (mutant C11 from pool 10) of the 
constructed library was catalase negative. This shows that integration of the tags into 
genomic DNA of the mutants has been occurred randomly, as some of the known 
phenotypic characteristics such as catalase production have been also affected. To test 
the virulence of the mutant, a mouse was injected intraperitoneally with an overnight 
culture of the mutant. The overnight culture of the wild type bacteria was also injected 
into another mouse. The details of the procedure are discussed in section 6.1. The 
number of recovered bacteria from the mice showed no discernible difference (figure 
5.3). It could be concluded that catalase did not affect the growth of bacteria in the 
mouse. The recovered bacteria from the mouse which had been injected with the 
mutant showed a negative catalase reaction. 
5.1.4 Conclusion 
A library of 825 mutants that contained unique tags, with random insertion of 
transposon Tn917 had been achieved. Thus the STM selection procedure is now 
working and can be used for mutant selection in the mouse and in biofilms. 
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Figure 5.3 Recovery the mutant C11 and wild type strains from mice 
24 hr post challenge 
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Chapter 6: Gene recovery from selected DNA sequences 
The constructed library was used in two experimental systems: a mouse infection 
model and in biofilms. 
6.1 Mouse infection 
A series of 25 pools of 33 mutants was used. Each pool contained 33 mutants with 
individual selected tags (see chapter 5 for details). The details of procedure for mouse 
infection and recovery of the bacteria from the mice was discussed in section 2.6.2. 
6.1.1 Response to infection 
At least one mouse was used for each pool. In some cases, 2-3 mice were used. All 
mice challenged intraperitoneally with 8x 105 CFU showed signs of illness (starry 
coat, hunched appearance, and lethargic) with different severity by 18 hr post- 
infection. By 24 hr post-infection, all the mice were killed by cervical dislocation. The 
spleens were removed into 2 ml of sterile PBS in a microfuge tube. 
6.2 Biofilm 
Discs of catheter material (surface area, 0.5 cm2) were cut from catheters, and 
sterilized by UV irradiation for 20-30 minutes each side. The discs were placed in 
wells of 24-well Nunclon tissue culture plates. A standardized cell suspension (80 µl) 
was applied to the surface of each disc, and the discs were incubated for 1h at 37°C. 
Non-adherent organisms were removed by gentle washing with PBS. To determine 
the suitable duration for biofilm formation, a series of experiments was done at 24 and 
48 h. After 24 h incubation, a layer of bacterial growth was seen on the discs, and the 
medium was clear. Although it seemed that growth of adherent bacteria was better 
after 48 h, the growth of nonadherent bacteria was also greater. As a consequence, the 
medium was cloudy in comparison with the 24 h volumes. Therefore, the 24 h 
incubation time was chosen for future experiments. At least 5 discs were used for 
each mutant. The discs were incubated for 24 h at 37°C, submerged in 1 ml of BHI 
with erythromycin (20 µg m1'). Discs without cells were incubated in the same way 
as for the control. After biofilm formation, the discs were removed from the medium 
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and gently washed with PBS to remove non-biofilm cells. Biofilm organisms were 
washed with 4 ml sterile BHI with erythromycin by vigorous moving of the container. 
The chromosomal DNA was extracted from the suspension. 
6.3 Membranes 
After making probes from the extracted genomic DNAs of the output pools from 
both experiments in mice and biofilm, at least one membrane was used for each pool, 
and hybridisation was done as described in section 2.4. The result of hybridisation of 
the 33 mutants of pool 8 from mouse experiment is shown in figure 6.1. Hybridisation 
signals from mutants A4, A9, B8 and D2 are present on the membrane with the input 
pool (a) but not on the membrane with the output pool (b). 
6.4 Southern blotting and hybridisation 
The mutants with attenuated virulence (which had weak or no signals on the output 
membranes) were subjected to the following procedure for gene recovery. 3-5 µg of S. 
aureus Chromosomal DNA from each mutant with attenuated virulence was 
completely digested with Hindlll. Half of the digested DNA was then subjected to 
Southern hybridisation analysis using a 723bp Pstl-AlwN1 fragment of pBR322 
containing part of the ß-lactamase gene as a probe to determine the size of the DNA 
fragment carrying this part of the transposon. The procedure for Southern blotting was 
described in section 2.5.1. The procedure for hybridisation of the membrane was the 
same as described in section 2.4. 
6.5 Cloning of attenuated genes 
The rest of the digested DNA in section 6.4 was resuspended in ligation buffer 
(Promega) and self-ligated for 12-18 h at 16°C. The ligated products were transformed 
into E. coli XL1-blue, plated onto LB agar containing amp and incubated at 37°C 
overnight. A single amp` colony from each transformation was grown in LB broth 
containing ampicillin. Plasmid DNA was extracted as described in section 2.2. Figure 
6.2 shows the Southern hybridisation analysis of 7 mutants from pool 8. As shown in 
the figure, the size of hybridising fragments in different mutants was different. 
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Figure 6.1 Hybridisation of the 33 mutants of pool 8 from mouse experiment. The membranes 
were hybridised with the probes from the input pool (a) and the output pool (b). Ilh-bridisation 
signals from mutants A4, A9, B8 and D2 are present on the membrane with the input pool but 
not on the membrane with the output pool. 
Figure 6.2 Southern hybridisation analysis of 7 mutants from pool 8. The DNAs were digested 
with Hind III and analysed by southern hybridisation using a fragment of the ß-lactamase gene 
of pBR322 as a probe. 
6.6 Analysis of the sequences 
Chromosomal DNA sequences flanking the transposon in the self-ligated 
constructed were obtained using primer pseq-1 corresponding to the inverted repeat 
region 70 bp from the erm-proximal end of Tn917. In total 12 samples with 
moderately attenuated hybridisation signals were sequenced. The sequencing was 
done by MBSU DNA Sequencing Service, University of Glasgow, UK. DNA 
sequences were analysed by searching the TIGR database on complete sequences of 
different S. aureus strains (Mu50, N315, COL, and MW2), BLAST and using 
DNASTAR software. Mu50 is an MRSA strain with vancomycin resistance isolated 
in 1997 from the pus of a Japanese male baby with a surgical wound infection that did 
not respond to vancomycin. N315 is an MRSA strain isolated in 1982 from the 
pharyngeal smear of a Japanese patient (88). MW2 is a MRSA strain which caused 
fatal septicaemia and septic arthritis in a 16-month-old girl in North Dakota, USA (9). 
The results are summarised in tables 6.1 and 6.2. 
6.6.1 Mutants from mouse experiments 
6.6.1.1 Mutant A4 (pool 8) 
The gene from this mutant was identified as encodes a hypothetical protein with a 
role in the group of hypothetical proteins. The gene had 100%, 100%, and 83.3% 
identity with SAV2655, SAS090, and MW1322 loci in S. aureus strains Mu50, N315, 
and MW2, respectively. In addition, the gene had 80%-92.9% identity with 5 different 
loci in each of the 3 strains. Figure 6.3 shows the region surrounding SAV2655 locus 
in S. aureus Mu50, and homology of the recovered gene and its protein. As shown in 
the figure, the most important genes surrounding the locus SAV2655 are intercellular 
adhesion protein B, C, and D with unclassified roles. 
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6.6.1.2 Mutant A9 (pool 8) 
The gene from this mutant was identified as a hypothetical protein with a role in 
DNA metabolism. The gene had 100% identity with the four strains of S. aureus. The 
homologous loci for the gene are SAV1394 (strain Mu50), SA1241 (strain N315), 
SA1445 (strain COL), and MW1229 (strain MW2). The gene also showed some 
identity with SE0979 in S. epidermidis, yojN gene in Bacillus subtilis 168, and 
OB0843 loci in Oceanobacillus iheyensis HTE831. All of the 3 are nitric-oxide 
reductase. Nitric-oxide reductase (NOR) is an enzyme involved in the denitrification 
process, in which nitrate (NO3) or nitrite (NO2) is converted into nitrous oxide 
(N20) via nitric oxide (NO). This enzyme catalyzes the reduction of NO to N20; 2N0 
+ NADH + H+ -º N20 + NAD+ + H2O, where NADH is an electron donor to the 
enzyme. The turnover number of this reaction is over 1,000 sec" at 10°C, showing an 
effective NO diminishing system in cells (148). Although there is no evidence on the 
specific effect of the enzyme in S. aureus, it seems as in other bacteria (24,143,162), 
the above general effect could decrease the side effects of NO on the cells. 
Figure 6.4 shows the homology between SAV1394 and yojN genes. The homology 
between the proteins SAV1394 with SE0979, yojN, and OB0843 is shown in figures 
6.5-6.7. The region view display of the SAV1394, yojN, and OB0843 are shown in 
figure 6.8. On one side, the loci SAV1392 and SAV1393 are a branched chain amino 
acid carrier protein, and conserved hypothetical protein, respectively. On the other 
side, there is SAV1395 locus which is a conserved hypothetical protein and has a role 
in protein fate. 
6.6.1.3 Mutant A9 (pool 9) 
The gene from this mutant was homologous with SAV1364 (100%), opp-2F 
(100%), SA1414 (91.7%), and MW1267 (98.7%) loci in S. aureus Mu50, N315, 
COL, and MW2 respectively. The gene had also some homology with SAV1363 
locus of S. aureus Mu50, and SE1060 locus in S. epidermidis. Figure 6.9 shows the 
protein homology between the recovered gene and SE1060 in S. epidermidis. The 
putative identification of locus SAV1364 is an oligopeptide transporter putative 
ATPase domain and belongs to the group of transport and binding proteins. This gene 
has also been identified in another STM screening on S. aureus (33). The surrounding 
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genes of the SAV1364 on the right side are a group of putative oligopeptide 
transporter genes that belongs to transport and binding proteins and have a role in 
protein synthesis. On the left side, there are some hypothetical proteins. The family of 
opps genes encodes the functionally diverse ATP-binding cassette (ABC) transporters 
proteins. The ATP-binding cassette (ABC) transporter proteins were the largest class 
which were identified by one of the STM screening on S. aureus (33). 
There are 2 ABC transporter operons in S. aureus, referred to as Opp-1 and Opp-2. 
The Opp-2 operon is near ORFs encoding the femA and femB genes that mediate 
pentaglycine peptidoglycan cross-linking of the S. aureus cell wall (152). S. aureus is 
naturally auxotrophic for several essential amino acids, and it is therefore possible 
that Opp mutants are defective in the import of peptides from which growth-essential 
amino acids are salvaged. In Gram-negative bacteria, a major function for the Opp 
system is the salvage of cell wall peptides released from growing peptidoglycan (62). 
Thus, it may be significant that the Opp-2 operon is in close proximity to the S. 
aureus Fern operon that encodes genes involved in cell wall peptidoglycan 
biosynthesis. Oligopeptide transporters are also known to play roles in growth 
regulation, cell competence, adherence to host cells and susceptibility or resistance to 
host defensins and toxic peptides (90,129,131). 
6.6.1.4 Mutant B8 (pool 8) 
The gene from this mutant was homologous with SAV1722 (100%), acuC (100%), 
SA1785 (99.5%), and MW1678 (99.2%) loci in S. aureus Mu50, N315, COL, and 
MW2 respectively. The gene had also some identity with acuC in S. xylosus, B. 
subtilis 168 and B. halodurans C-125 (figure 6.10). The gene is surrounded by a 
series of different genes which have some roles in metabolism, regulatory functions, 
and amino acid biosynthesis. 
This gene has been also identified in other bacteria like B. subtilis (169), but not in 
any of the previous STM works on the S. aureus. This gene was identified in an 
output from a mouse infection experiment. acuC encodes the enzyme acetoin 
dehydrogenase and disruption of this gene results in poor growth or sporulation on 
acetoin in B. subtilis (65). The homology between the proteins of the SAV1722 with 
acuC in S. xylosus, B. subtilis, and B. halodurans are shown in figures 6.11-6.13. 
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6.6.1.5 Mutant 1311 (pool 9) 
The gene from this mutant was homologous with SAV1362 (100%), SA1209 
(100%), SA1412 (98.0%), and MW1265 (98.2%) loci in S. aureus Mu50, N315, 
COL, and MW2 respectively. SAV1362 is a conserved hypothetical protein with 
unknown function. The surrounding genes of the SAV1362 are the group of 
oligopeptide transporter putative genes with a role in protein synthesis on one side, 
and some hypothetical proteins on the other side. SAV1362 and SA1412 encode 
putative hydrolase enzyme. Homology between the recovered gene and SA1362 is 
shown in figure 6.14. 
6.6.1.6 Mutant D2 (pool 8) 
The gene from this mutant was 100% homologous with SAV1474, SA1316, 
SA1526, and MW1373 loci in S. aureus Mu50, N315, COL, and MW2, respectively. 
The gene had also some identity with SE1174 in S. epidermidis, ypaA in B. subtilis 
168 and OB2329 in 0. iheyensis HTE831 (figures 6.15-6.17). SAV1474 is a 
conserved hypothetical protein. All of the surrounding genes of SAV 1474 locus are 
hypothetical proteins, except the SAV1473 locus which contains the ferredoxin gene 
which has a role in energy metabolism. Figure 6.18 shows the region view of 
SAV1474 in S. aureus Mu50, ypaA in B. subtilis 168, and OB2329 in 0. iheyensis 
HTE831, which both have an unclassified role. The homology of the recovered gene 
with the SAV1474 locus in S. aureus Mu50 is shown in figure 6.19. 
Work on ypaA gene in B. subtilis has showed that after inactivation of the gene, the 
phenotypic pattern obtained showed that this gene controls a system for active flavin 
transport and, possibly, riboflavin excretion under the conditions of constitutive 
synthesis (87). 
6.6.1.7 Mutant F11 (pool 9) 
The gene from this mutant was homologous with SAV1369 (100%), SA1216 
(100%), SA1419 (99.8%), and MW1272 (99.8%) loci in S. aureus Mu50, N315, 
COL, and MW2, respectively. The SAV1369 and SA1419 encode oligoendopeptidase 
F (pepF), and the loci SA1216 and MW1272 are similar to oligoendopeptidase. The 
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surrounding loci of SAV1369 belong to the group of transport and binding proteins. 
The gene had also some identity with S. epidermidis and 0. iheyensis. Figure 6.20 
shows the homology between the recovered gene (SAV1369 locus in S. aureus Mu50) 
and SE 1065 locus in S. epidermidis. 
PepFs are cytoplasmic endopeptidases that hydrolyze oligopeptides but cannot 
degrade proteins (140). They are usually named oligopeptidases and constitute a sub- 
group of the endopeptidase family. Several enzymes of the oligopeptidase family have 
been found in mammals. A thimet (thiol-dependent metallo) oligopeptidase was 
purified from various species and tissues. It hydrolyzes peptides which are 6-18 
amino acids long. Oligopeptidases are generally characterized by substrate size 
specificity. It was shown that PepFl did not cleave peptides containing fewer than 7 
or more than 17 amino acids. The substrate size specificity of oligopeptidases is 
probably related to their role in the cells (170). It seems likely that, in mammals, 
oligopeptidases participate in the later steps of the degradation of proteins and in the 
hydrolysis of peptides in the cytoplasm. In addition, they could have a regulatory 
function on bioactive peptides like bradykinin, enkephalin precursors, luliberin, 
neurotensin, and angiotensin. The role of oligopeptidases was also investigated in 
bacteria. OpdA and the dipeptidyl carboxypeptidase of S. typhimurium are involved in 
protein turn-over as revealed by the study of a double negative mutant for both 
enzymes. In such a mutant, the release of trichloroacetic acid-soluble material due to 
protein degradation is only 70% of that obtained in the wild strain. These peptidases 
probably hydrolyze the peptide intermediates formed in the protein breakdown 
pathway. In E. coli, OpdA could play a role in association with the membrane-bound 
protease IV. The two enzymes are able to degrade in vitro prolipoprotein signal 
peptides. In vivo, it is probable that OpdA degrades the products of the initial cleavage 
of the signal peptide by protease IV that may diffuse into the cytoplasm (123). 
Lactococcus lactis has a complex proteolytic system which is essential for its 
growth in milk. Several oligopeptides have been also purified in lactococci (158, 
170). According to the substrate specificities investigated, only two different enzymes 
are apparently present in L. lactis. PepFl and PepF2 are plasmid- and chromosomally 
encoded gene products, respectively, of L. lactis strain NCD0763. They belong to the 
M3 family of peptidases that includes the mammalian oligopeptidase 24.15 (140). The 
gene corresponding to the lactococcal oligopeptidase PepFl is located on the lactose- 
proteinase plasmid of L. lactis subsp. cremoris NCD0763 (120). The gene in L. lactis 
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was found on a 55 kb plasmid, which also carries the genes coding for lactose 
utilization and for the cell envelope-associated proteinase which are essential for 
growth in milk. The gene sequence exhibits similarity around the catalytic site with 
the thimet oligopeptidase and with the bacterial oligopeptidases isolated from E. coli 
and S. typhimurium (124). pepF1 and pepF2 exhibit 80% identity and encode two 
proteins which are 84% identical (120). 
The yjbG gene in B. subtilis encodes a protein highly homologous to the PepFl and 
PepF2 oligopeptidases of L. lactis (84,117,120). The oligopeptidase pepB in group B 
streptococci has also showed high similarity to PepF in L. lactis (97). Although the 
homology of the recovered gene and pepF and their proteins in other bacteria is 
strong, there is no evidence on specific function of the gene in S. aureus. In other 
words, it seems the enzyme acts in hydrolysis of oligopeptides like other bacteria. 
6.6.1.8 Mutant G12 (pool 9) 
The gene from this mutant was homologous with SAV2190 (100%), SA2005 
(100%), and SA2196 (99.6%) loci in S. aureus Mu50, N315, and COL respectively. 
Figure 6.21 shows the region view of SAV2190 locus. SAV2190 encodes a conserved 
hypothetical protein. The surrounding loci of the SAV2190 belong to different groups 
such as protein fate, cell envelope, metabolism, and amino acid biosynthesis. The 
homology of the recovered gene from mutant G12 with SAV2190 is shown in figure 
6.22. 
6.6.1.9 Mutant H3 (pool 9) 
The gene from this mutant was homologous with SAV1373 (100%), SA1220 
(99.7%), SA1423 (99.0%), and MW1276 (99.0%) in S. aureus Mu50, N315, COL, 
and MW2 respectively. These loci have high homology to SAV1372, SA1219, 
SA1422, and MW1275 loci in the same strains of S. aureus respectively. The putative 
identification for these loci is phosphate ABC transporter, psiC and pstA which 
belong to the group of transport and binding proteins. The gene had also some identity 
with BH2993 in B. halodurans C-125 and OB3135 in 0. iheyensis HTE831. The 
region view of the 3 loci is shown in figure 6.23. The main group of surrounding 
genes is transport and binding proteins. The putative identification for this homology 
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is also phosphate ABC transporter (permease). The gene had the same identity with 
different percentage of homology with some other gram positive such as S. 
epidermidis and gram negative bacteria. Figures 6.24-6.26 show the protein homology 
of recovered gene (SAV1373 in S. aureus Mu50) and SE1069 in S. epidermidis, 
BH2993 in B. halodurans, and OB3135 in 0. iheyensis respectively. 
ATP binding cassette (ABC) transporters of pathogenic staphylococci are often 
responsible for antibiotic resistance and for the uptake of essential solutes and are 
therefore being considered as targets for novel antistaphylococcal drugs. Other ABC 
transporters are involved in the biosynthesis of a special class of peptide antibiotics, 
the lantibiotics, and in self-protection of the producer against them (128). 
Bacteria can acquire resistance to antibiotics, among other possible mechanisms, by 
removing the antibiotics from their place of action, often by using drug exporters. In 
staphylococci, many drug exporters are known, some of which are ABC transporters. 
MsrA and VgaB are two ABC transporters in staphylococci which confer resistance to 
erythromycin and streptogramin respectively (128). Many of the proteins involved in 
cell wall metabolism have been found via their ability to confer resistance to 
methicillin. Adjacent to the gene for penicillin-binding protein 4 (pbpD), an ABC 
transporter is encoded, which is thought to influence the resistance phenotype by 
regulatory means and not by serving as an efflux pump (46). 
Several ABC transporters have been found in an approach which genetic loci with 
an impact on growth and survival of S. aureus during infection were identified (33). 
Furthermore, an ABC transporter has been identified as the immunodominant protein 
during S. aureus infections (23). Both findings demonstrate that ABC transporters 
will play an important role as target molecules in the search for novel 
antistaphylococcal therapies. Oligopeptide transporters are also known to play key 
roles in growth regulation, cell competence, adherence to host cells and susceptibility 
or resistance to host defensins and toxic peptides (33). 
6.6.1.10 Mutant H5 (pool 9) 
The gene from this mutant was homologous with SAV1362 (100%), SA1209 
(100%), SA1412 (98.0%), and MW1265 (98.2%) loci in S. aureus Mu50, N315, 
COL, and MW2 respectively. The surrounding genes of the SAV1362 are the group 
of oligopeptide transporter putative genes with a role in protein synthesis on one side, 
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and some hypothetical proteins on the other side. SAV1362 and SA1412 locus is a 
putative hydrolase. The gene had strong identity with MW 1264 as well. The gene had 
also identity with flaR gene in L. monocytogenes, and some identity with S. 
epidermidis. F1aR is a histone-like bacterial protein which acts at specific sites to 
influence DNA topology and, therefore, transcription. flag has different roles in DNA 
metabolism such as DNA replication, recombination, and repair. flag is the first gene 
of this class that has been described in gram positive pathogenic bacteria (142). Figure 
6.27 shows the homology between recovered gene and its protein (SAV1362 locus in 
S. aureus Mu50) with LM02669locus (f7aR) in L. monocytogenes. 
6.6.2 Mutants from biofilm experiments 
6.6.2.1 Mutant F10 (pool 1) 
The gene from this mutant had 100% homology with SAV1382, dapD, SA1432, 
and MW1285 loci in S. aureus Mu50, N315, COL, and MW2 respectively. The gene 
had also some identity with OB1402 in O. iheyensis HTE831, EF1133 in 
Enterococcus faecalis V583, BH2669 in B. halodurans C-125, and several other gram 
positive and gram negative bacteria. The SAV1382 locus belongs to the group of 
amino acid biosynthesis which are also the next 3 genes on the left side, and one on 
the right side. The other surrounding genes belong to metabolism and cell envelope 
groups. Figure 6.28 shows the region view of SAV1382 in S. aureus Mu50, OB1402 
in O. iheyensis HTE831, EF1133 in E. faecalis V583, and BH2669 in B. halodurans 
C-125. The homology of the recovered gene with SAV1382 locus in S. aureus Mu50 
is shown in figure 6.29. Protein homology of dapD (locus SAV1382 in S. aureus 
Mu50) with SE1077 locus in S. epidermidis is shown in figure 6.30. 
The recovered gene from this mutant was identified as tetrahydrodipicolinate 
succinylase homolog. This gene was from one of the biofilm experiments. The dap 
operon contains 6 genes involved in the biosynthesis of lysine. Tetrahydrodipicolinate 
N-succinyltransferase (dapD) is essential in amino acid biosynthesis and catalyzes the 
succinyl-CoA-dependent acylation of L-2-amino-6-oxopimelate to 2-N-succinyl-6- 
oxopimelate as part of the succinylase branch of the meso-diaminopimelate/lysine 
biosynthetic pathway of bacteria, blue-green algae, and plants. This pathway provides 
meso-diaminopimelate as a building block for cell wall peptidoglycan in most 
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bacteria, and is regarded as a target pathway for antibacterial agents (15). It has been 
shown that the enzyme is a sulfhydryl enzyme and involved in diaminopimelate and 
lysine biosynthesis. It has a pH optimum of 8.2. The enzyme has been identified in 
another STM screening on S. aureus (33), and in other gram positive and gram 
negative bacteria like E. coli (105,149). 
A model system of growth in serum has been shown to be useful for the 
identification of genes which may contribute to the establishment (surface protein 
genes) and the persistence (biosynthetic genes) of S. aureus in the bloodstream. The 
serum screen is a simple and complementary approach to both STM and IVET and 
may allow environmental parameters important in the host to be elucidated. Several 
genes including dapA have been identified in S. aureus by using the serum screen 
(168). 
This work is the first that has used the STM method in biofilm systems. This is also 
the first time that the dapD gene has been recovered from a gene screening in biofilm, 
although it needs more work to confirm the exact role of the gene in biofilm 
formation. The enzyme has been identified in another STM screening on S. aureus 
(33). This work also showed that the STM method works well, as confirms other 
findings. 
6.6.2.2 Mutant F11 (pool 1) 
The gene from this mutant was homologous with SAV1393 (100%), SA1240 
(100%), SA1444 (99.7%), and MW1298 (99.7%) loci in S. aureus Mu50, N315, 
COL, and MW2 respectively. The gene had also some identity with branched-chain- 
amino-acid transporter of S. aureus. The homology between the recovered gene and 
the branched-chain-amino-acid transporter is shown in figure 6.31. The gene had also 
some identity with yojO in B. subtilis 168 and OB0842 in O. iheyensis HTE831. 
Figure 6.32 shows the region view of SAV1393 in S. aureus Mu50, yojO in B. subtilis 
168, and OB0842 in 0. iheyensis HTE831. 
The recovered gene had some identity with branched-chain-amino-acid transporter 
of S. aureus. The branched-chain-amino-acid transport gene (brnQ) encodes a highly 
hydrophobic polypeptide. The polypeptide has high homology to the Na+-dependent 
branched-chain-amino-acid carriers in several gram negative bacteria, and branched- 
chain-amino-acid carriers in several gram positive bacteria (165). 
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Figure 6.8 Region view display of the SAV1394 locus in S. aureus Mu50 (top), yojN in B. subti/is 
168 (middle), and OB0843 in 0. iheyensis HTE831 (bottom) 
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Figure 6.10 Region view display of the SAV1722 locus in S. aureus (Mu50), acuC (N315), acuC in 
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Figure 6.18 Region view display of the SAV1474 locus in S. aureus Mu50 (top), ypaA in B. subti/is 
168 (the middle), and OB2329 in O. ihevensis HTE83I (bottom). 
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Figure 6.21 Region view display of the SAV2190 locus in S aureus Mu50 
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Figure 6.23 Region view display of the SAV1373 locus in S. aureus Mu50 (top), BH2993 in B. 
halodurans C-125 (the middle), and OB3135 in 0. iheyensis HTE831 (bottom). The light green 
arrows indicate transport and binding proteins group. 
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Figure 6.28 Region view display of the SAV1382 locus in S. aureus Mu50 (top), OB1402 in O. 
iheyensis HTE831 (the second), EFI 133 in Enterococcus faecalis V583 (the third), and BH2669 in 
B. halodurans C-125 (bottom). 
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Figure 6.32 Region view display of the SAV1393 locus in S. aureus Mu50 (top), yojO in B. subtilis 
168 (the middle), and OB0842 in O. iheyensis HTE831 (bottom). 
Note: There are some rearrangement of the SAV1394 and SAV1395 loci in the sequence of the 
whole genome, as the two loci are also seen with different sizes in the opposite direction (see 
figure 6.28). 
Part III 
Discussion 
Chapter 7 
General discussion 
Chapter 7: General discussion 
S. aureus is a highly versatile pathogen, well adapted to survive in many niches in 
and on humans. The ability of S. aureus to evade the host immune response and cause 
disease is due to an extensive repertoire of both known and unknown virulence 
factors. Much of our knowledge about the virulence determinants of pathogenic 
bacteria comes from experiments with bacteria grown in culture, but there is currently 
an increasing interest in what happens to bacterial pathogens in the infected host. In 
the past few years, the study of bacterial pathogenesis has been advanced by a number 
of techniques that enable investigators to monitor bacterial gene expression during 
infection. These techniques allow the investigator to select and screen for genes that 
are required for infection or that are expressed in vivo. Two main categories of these 
techniques are in vivo expression technology (IVET) and signature-tagged 
mutagenesis (STM). Both methods have been used to identify virulence genes in S. 
aureus. The aim of this project was to find any probable new genes of S. aureus that 
is essential for biofilm formation and in a mouse infection model by STM. 
IVET has been applied to S. aureus using a promoter trap that relies on genetic 
recombination of the site-specific resolvase of tnpR from gamma delta (Tn1000) as a 
reporter of gene expression. A collection of 45 genes were found induced during 
infection in a murine renal abscess model. Of these, only six had been known 
previously; 11 others have homology to known non-staphylococcal genes. The known 
staphylococcal genes included agrA, a key locus regulating numerous virulence 
products; and a glycerol ester hydrolase which may enhance bacterial survival in 
abscesses. Many of the ivi genes identified were not classical virulence factors but 
rather involved in adaptation to the in vivo environment; knowledge of these 
biochemical pathways is clearly the next phase in IVET systems (98). 
STM is a powerful genetic method, developed by David Holden and his colleagues 
in 1995, to identify genes in pathogens that are required for growth in an animal. In 
essence, STM enables one to test a large number of potential mutants simultaneously 
in one animal, and to identify and recover mutants that fail to colonize host tissues. 
Factors identified by STM are essential for colonization in the niche tested. This 
feature is unique to STM among various genomic strategies developed thus far to 
study pathogens in vivo. Other methods, such as IVET, DFI and microarray analysis, 
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identify genes whose expression is induced in the host; additional experiments are 
required to determine whether the gene is necessary for colonization of host tissues. 
During the past seven years, STM has been successfully applied to a large variety of 
bacterial pathogens in hosts ranging from cows to amoeba to cultured cells. In most 
studies, both predicted and unsuspected virulence factors have been identified and 
include a vast variety of proteins involved in different functions, as well as open 
reading frames (ORFs) with unknown function or with no homology to other genes in 
GenBank. 
Mutagenesis techniques have been used extensively for the identification of genes 
whose functions are required under certain conditions. One of these techniques that 
has been used in several pathogens is transposon mutagenesis. Three limitations of the 
transposon mutagenesis approach should be kept in mind. 
First, transposons carry transcriptional terminators. If a transposon lands in the first 
gene in an operon, it will eliminate expression not only of that gene but also of 
downstream genes as well; in other words, transposon insertions are polar. The 
avirulent phenotype of the mutant could thus be due to loss of expression of either the 
gene interrupted by the transposon or downstream genes in the operon. 
A second limitation is that transposon insertion mutants can be obtained only in 
genes that are not essential for growth on the selective medium. A transposon 
insertion in a gene essential for growth will not be isolated because the bacteria will 
not survive to form a colony. This could be considered an advantage if one assumes 
that the most interesting virulence genes are not the ones essential for growth in 
laboratory medium but are genes induced specifically in an animal host (141). The 
most important disadvantage of transposon mutagenesis is that to screen for loss of 
virulence would require each mutant to be tested separately. So, we need methods to 
label individual mutants, and then pools can be screened. In other words, a number of 
mutants (e. g., 96 from a microtiter dish) can be screened simultaneously. 
The third limitation is that transposon mutagenesis is not fully random and may 
have favoured mutation of certain areas of the chromosome over others (29). 
As STM is based on transposon mutagenesis, it has the above limitations. It should 
be also noted that, depending on the sensitivity of the PCR/hybridisation protocol for 
detecting such changes in tag populations, STM might not identify mutations causing 
small or even moderate reduction in survival. This is a particularly important 
consideration because this category includes mutations in genes that are critical for 
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causing disease but do not appreciably affect survival of the bacterium in the host. For 
example, it is the action of cholera toxin that is primarily responsible for the lethality 
of cholera, but deletion of the cholera toxin genes does not affect the bacterium's 
ability to colonize the host (159). 
In the first step of the project, a library of S. aurcus tagged insertion mutants was 
given to us by Professor Holden. A series of artificial input and output pools was 
chosen and hybridisation experiments were done. Cross-hybridisation was seen in 
most of the experiments. According to the results of the hybridisation experiments on 
the existing library, it was concluded that the library was not reliable for a cross- 
hybridisation free screening. There are at least 3 possible reasons for this problem, (i) 
the problem with hybridisation itself, (ii) incomplete removal of the arms of the tags 
in the process of digestion and making the probes, and (iii) contamination of the tags. 
The first 2 possibilities are excluded as they are not supported by some series of 
experiments, and as results showed the protocol worked in some experiments. It is 
therefore concluded that the problem was more likely the contamination of the 
mutants with each other or original tags used to make the library. This could have 
occurred in the first inoculation from the master plates (which contain all the 
representative tags in each plate) to the cryotubes. As the existing library of mutants 
showed unexpected cross-hybridisation, the whole library was discarded. The details 
of experiments on the existing library are presented in chapter 3. We next tried to use 
the selected tags in plasmids of S. aureus strain RN6390 for future experiments. 
In the second step of the project, the selected tags in plasmids of S. aureus RN6390 
were used. The plasmids were also given to us by Professor Holden. A series of 
artificial input and output pools was chosen and hybridisation experiments were done. 
Cross-hybridisation was seen in most of the experiments. 4 plasmids which had cross- 
hybridisation were sequenced. The results showed that 3 out of 4 were exactly the 
same. It was therefore decided that all 94 tags should be sequenced. 84 out of 94 were 
sequenced. The results showed that 51 out of 84 had more than 50% identity, and 
were not therefore suitable for a cross-hybridisation free screening. 33 tags with less 
than 50% identity were chosen for future experiments. The details of the experiments 
on the selected tags in plasmids of S. aureus are presented in chapter 4. 
In the third step of the project, we tried to construct a new library of mutants from 
the 33 selected tags. A library of 825 mutants, divided into 25 pools of 33 individually 
tagged members was constructed for future experiments. Several random mutants 
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from the library were chosen and tested in two ways. The results showed that (i) the 
constructed mutants lacked the plasmid and carry a single chromosomal insertion of 
Tn917, and (ii) there was no cross-hybridisation between the mutants of the 
constructed library. In addition, to determine the mutagenesis had occurred randomly 
across the genomic DNA of the mutants of the constructed library, all the mutants of 
the constructed library were tested for catalase enzyme production individually. As 
there was one catalase-negative mutant in the library, this showed that loss of known 
phenotypes could be detected. In other words, mutagenesis has also occurred in 
known genes such as catalase gene. The details of the construction of the library of 
tagged insertion mutants are presented in chapter 5. 
In the fourth and last step of the project, the constructed library was used in two 
experimental systems: mouse infection and biofilm. The mouse infection model has 
been used before (33,112,146), but STM in biofilm experiments has been done for 
the first time. Totally 25 pools of 33 mutants were screened at least once in each 
model. The DNA regions flanking the pBR322 side of the transposon insertion points 
of 12 mutants were cloned as described before in section 6.5. The nucleotide 
sequences of the flanking regions were determined and subsequently analysed by 
searching the DNA and protein databases for identical or similar genes (tables 6.1 & 
6.2). The details of gene recovery from the attenuated mutants are presented in 
chapter 6. 
To determine the mutagenesis had occurred randomly across the genomic DNA of 
the mutants of the constructed library, some of the known phenotypic characteristics 
can be traced. Catalase production was chosen for this purpose. The results showed 
that 1 out of 825 mutants of the constructed library was catalase negative. This shows 
that integration of the tags into genomic DNA of the mutants has been occurred 
randomly, as some of the known phenotypic characteristics such as catalase 
production have been also affected. The catalase negative and wild type strains were 
injected intraperitoneally into mice. The number of recovered bacteria from the mice 
showed no discernible difference (figure 5.3). It could be concluded that catalase does 
not affect the growth of bacteria in mouse. 
The recovered genes in this project can be viewed in different aspects. The first is 
the homology between these genes and those from the published complete sequences 
of four strains of S. aureus, and other bacterial genomic sequences in GeneBank. In 
this view, some of the recovered genes have strong homology with the four strains, 
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and some other gram positive and gram negative bacteria, as well. There are some 
recovered genes that have homology just with the four strains of S. aurcus. The third 
and last group which includes two genes had homology just with 3 out of the four 
strains. It seems that this could be usual, as there are more than 2500 ORFs in the 
complete sequence of S. aureus, and there are some differences between different 
strains within a species. On the other hand, bacteria have usually some identical or 
common genes, and this should be much closer within a definite group such as gram 
positive and gram negative bacteria. 8 out of 12 genes had some identity with S. 
epidermidis, and the same number had some identity with other bacteria especially 
gram positive bacteria. 
The second point of view could be the kind of recovered genes, and their role in the 
cells. In addition, the results could be compared with other searches especially those 
that have done using STM method. 4 out of 12 recovered genes in current study were 
in the transport and binding proteins group. This maybe represents the frequency and 
the number of such genes in comparison to the total number of genes in the whole 
genome. The other possibility, as discussed before, is that transposon mutagenesis is 
not fully random and may have favoured mutation of certain areas of the chromosome 
over others (20). As STM has based on transposon mutagenesis, it may show this 
limitation in some cases. 
There were 4 out of 12 sequences identified as conserved hypothetical protein 
and/or hypothetical protein with unknown function and one with a role in DNA 
metabolism. All of these sequences were from mice infection experiments. The whole 
genome of S. aureus Mu50 and N315 has 2697 and 2595 open reading frames 
respectively including 70 putative virulence factors (88). According to the high 
number of genes in the genome of S. aureus, it seems that it is usual to find some of 
the genes as hypothetical proteins with unknown function in such projects. 
One of the conserved hypothetical proteins with locus 1362 has been identified in 2 
strains (B 11 and H5) of output pools from the mice experiments. 
Several sequences showed different homology with O. iheyensis HTE831 and B. 
subtilis. O. iheyensis is an extremely halotolerant and alkaliphilic gram positive, 
strictly aerobic, rod-shaped, motile by peritrichous flagella, and spore forming. 
Phylogenetic placement of the bacterium is comparatively close to that of B. subtilis 
(100). The genome of the bacterium also contains 27 putative phage-associated genes, 
which are similar to those of several bacteria including S. aureus and B. subtilis (157). 
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Media are made selective for staphylococci by including 7.5% (w/v) NaCl. 
Staphylococci can tolerate unusually high NaCl concentrations, with S. aurcus 
capable of growth in media of water activity (aW) of 0.86, which is equivalent to 3.5 
M (20%) NaCI (36). That is not surprising that there is some homology between S. 
aureus and O. iheyensis genomes, as high NaCl tolerance is common in both bacteria. 
In total 12 (1.45%) samples showed moderately attenuated hybridisation signals in 
this study. This is less than the number of attenuated mutants in other works by Mei et 
al (112) and Coulter et al (33) which were 50 (4.01%) and 237 (7.11-8.36% in 
different infection environments) respectively. In the last work, only 85 out of 237 
mutants were sequenced. 
Virulence in S. aureus has been studied by using STM methodology (33,112,146). 
In the study by Mei et al (112), Tn917 mutants were tested in a murine model of 
bacteraemia. The majority of loci from 50 mutants that were identified as attenuated 
were predicted by sequence similarity to be involved in cell surface metabolism (e. g. 
peptidoglycan cross-linking and transport functions), nutrient biosynthesis, and 
cellular repair processes, but most of the remainder had no known function. A slightly 
larger signature-tagged mutant bank was constructed by using the same transposon 
and tested in models of bacteraemia, abscess and wound formation, and endocarditis 
(33). This enabled the identification of various genes affecting growth and virulence 
in specific disease states, as well as 18 that are important in at least three of the 
infection models. Many of these genes appear to be involved in the same kinds of 
processes as those identified in the earlier study (112); indeed, several genes 
identified by Mei et al (112) were also found by Coulter et al (33). As in these earlier 
studies, both predicted and unsuspected virulence factors, as well as ORFs with 
unknown function have also been identified in the present study. Two genes identified 
in this work were also found by Coulter et al (33). This similarity shows: first, our 
system with the new constructed library worked properly, and second, this maybe 
strengthen the opinion that transposon mutagenesis (including STM) is not fully 
random, and may have favoured mutation of certain areas of the chromosome over 
others. 
The assortment of independent mutations recovered in peptide and amino acid 
transport mechanisms emphasizes the biological significance of these loci on S. 
aureus survival in single or multiple in vivo environments. 
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This work is the first that use the STM method in biofilm systems. This is also the 
first time that dapD gene has been recovered from a gene screening in biofilm, 
although it needs more work to confirm the exact role of the gene in biofilm 
formation especially in S. aureus. The enzyme has been also identified in a mouse 
infection model in another STM screening on S. aureus (33). In other words, this 
work also showed that the STM method works well, as confirms other findings. It 
could also be concluded that there is a link between biofilm formation and infection in 
vivo, as the enzyme has been identified in both systems. 
This work could be followed in different ways in future. The more the number of 
tag insertion mutants in the library are, the more efficient the screening will be. In 
addition, it is advisable to make defined single mutations to determine and confirm 
the role of the genes in more details, e. g. defined mutant relating to nitric-oxide 
reductase and test susceptibility to NO in vitro. 
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Appendix 
Materials 
Appendix: Materials 
Agarose MP (multi purpose agarose): 
Roche Diagnostics GmbH, # 1388991 
Ampicillin stock solution: 
Sigma, # A-9518,50 mg/ml 
Brain heart infusion (BHI) agar: 
Oxoid, # CM225,37 gr/litre with 1.5% agar, autoclaved 
Brain heart infusion (BFII) broth: 
Oxoid, # CM225,37gr/litre, autoclaved 
Blocking Reagent stock solution: 
Roche Diagnostics GmbH, # 1096176, Blocking reagent was dissolved in maleic acid 
buffer to a final concentration of 10% (w/v) with shaking and heating, and then 
autoclaved. 
Chloramphenicol stock solution: 
Sigma, # C-0378,20mg/ml 
Chloroform: 
Fisher Scientific, # C/4960/17 
CSPD® (Disodium 3-(4-methoxyspiro{1,2-dioxetane-3,2'-(5'- 
chloro)tricycle[3.3.1.13'7]decan}-4-y1) phenyl phosphate: 
Roche Diagnostics GmbH, # 1755633 
CTAB/NaCI (10% hexadecyltrimethyl ammonium bromide in 0.7 M NaCI): 
4.09 g NaCl was dissolved in 80 ml distilled water. 10 g CTAB was added and mixed. 
20 ml of distilled water was added. The solution is viscous, and should be 
homogenised by using stirrer and microwave. 
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Denaturation solution: 
0.5 N NaOH, 1.5 M NaCI 
Detection buffer: 
100 mM Tris-HCI, pH 9.5 (+20°C), 100 mM NaCI 
Epicurian Coli® XL1-Blue Competent Cells: 
Stratagene, # 200249 
Erythromycin stock solution: 
Sigma, # E-6376,20 mg/ml 
Ethanol: 
Bamford Laboratories, # 200-578-6 
Glycerol: 
Sigma-Aldrich GmbH, # 15523 
Hind III: 
Life technologies, # 15207-012 
Hybond® N+ Nylon membrane: 
Amersham Pharmacia Biotech, # RPN203N 
Hydrogen peroxide: 
Sigma, # H-1009,30% 
Iso-amyl alcohol: 
Fisher Scientific, # A/7080/08 
Isopropanol (Iso-propyl alcohol): 
BDH Company, # 10224BQ 
1 Kb DNA Ladder: 
Life Technologies, # 15615-016 
75 
25 bp DNA ladder: 
Invitrogen, Life technologies, # 10597-011 
Luria-Bertani (LB) agar: 
Sigma, # L-3522,25 gr/litre, with 1.5% agar, autoclaved 
Luria-Bertani (LB) broth: 
Sigma, # L-3522,25 gr/litre, autoclaved 
Lysostaphin: 
Sigma, # L-0761; 3M Sodium acetate pH 5.2,33.3 µl; distilled water 966.7 µl 
Lysozyme stock solution: 
Sigma, # L-6876 
Maleic acid buffer: 
Sigma, # M-0375,0.1M Maleic acid, 0.15 M NaCl, pH 7.5 (+20°C), adjust pH with 
concentrated or solid NaOH, autoclaved 
NaCI: 
Sigma-Aldrich GmbH, # 31434 
Neutralization solution: 
0.5 M Tris-HCI, pH 7.5,3 M NaCI 
N-lauroylsarcosine: 
10% (w/v) in sterile H2O, filtered through a 0.2-0.45 µm membrane 
PCR DIG Labelling Mix: 
Roche Diagnostics GmbH, # 1585550 
76 
Primers: 
P1 (5'---3') 
CTT CAA TTC CTA TTA TAC 
Modification: 5' IRD 700 
P2 (5'->3') 
CAT ATT TGA ATG TAT TTA G 
Modification: 5' IRD 800 
P12 (5'--*3') 
ATT CTA CAA CCT CAA GC 
P13 (5'->3') ' 
ATT CCA TTC TAA CCA AGC 
P21 (5'-3') 
TAA GAC ACG ACT TAT CGC CA 
P22 (5'-->3') 
CGT TGC GCA AAC TAT TAA CT 
Pseq-1 (5'--+3') 
AGA GAG ATG TCA CCG TCA AGT 
P009823 (5'->3') 
CAA CAT GAC GAA TCC CTC C 
P009824 (5'-43') 
GGG AAT AAG GGC GAC ACG 
Proteinase K stock solution: 
Life Technologies, # 25530-015,20 mg/ml distilled water 
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RNase: 
10 mg/ml, Qiagen 
SDS stock solution: 
Fisher scientific, # S/P530/53,10% (w/v) in H2O, filtered through a 0.2-0.45 µm 
membrane 
SET, pH 7.5: 
20% sucrose, 50 mM EDTA, 50 mM Tris Base 
SSC stock solution (20x): 
3M NaCI, 0.3 M sodium citrate, pH 7.0 (+20°C), autoclaved 
Standard hybridization buffer: 
5x SSC, 0.1% N-lauroylsarcosine, 0.02% SDS, 1% Blocking Reagent (from the 10% 
Blocking Reagent stock solution) 
Taq DNA polymerase: 
Promega, # M1861 
T4 DNA Ligase: 
Promega, # M1801 
TE buffer: 
10 mM Tris-HC1,1 mM EDTA, pH 8.0 (+20°C) 
Trizmä Base (Tris [hyd roxymethyll amino methane): 
Sigma, # T-1503 
Trizmä Hydrochloride (Tris[hydroxymethyl] aminomethane hydrochloride): 
Sigma, # T-3253 
Tween 20 (Polyoxyethylene-sorbitan monolaurate): 
Sigma, # P-1379 
78 
Washing buffer: 
Add 0.3% (w/v) Tween 20 to Maleic acid buffer. 
Washing solution 2x: 
2x SSC, 0.1% SDS 
Washing solution 0.5x: 
0.5x SSC, 0.1% SDS 
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